Category: Taxation

Posted on

Speech to the Automobile Association Annual Conference

Source: New Zealand Government

Introduction

Good afternoon. Thank you, Brett, for the introduction and everyone for the warm welcome.

I am excited to be here to talk with you today about transport funding, the transition to Road User Charges, and improvements to road safety, including our road toll and oral fluid testing.

I’d like to acknowledge Deputy Mayor Desley Simpson for her opening address today. We’ve seen a lot of each other lately, but it’s always good to see you!

I’d also like to acknowledge AA Chief Executive Nadine Tereroa and President Brett Flintoff.

Finally, I’d like to also acknowledge the many AA district councillors and AA staff who are here today. Thank you for the work you do to serve your members and be an advocate for the things that matter to New Zealand motorists.

Fuel Supply Shock

To begin, I would like to acknowledge the challenges the transport system, and all New Zealanders, are currently navigating due to the current fuel supply shock as a result of the conflict in the Middle East.

Right now, we know the conflict in the Middle East is causing concerns across the country and across the world about supply of fuel.

We have sufficient stocks in New Zealand and we are working hard across diplomatic, commercial, and industry channels to ensure that remains the case.

But this situation is also a reminder of something we already knew: New Zealand is exposed to international fuel markets in ways that carry real risk.

Around half our fuel comes from South Korea and nearly a third from Singapore.

When global supply chains are disrupted, as they are now, that exposure becomes very tangible for families and businesses who feel the pain at the pump.

We are already seeing significant shifts in behaviour across the country, and as a government we are closely monitoring these changes so we can respond to their impacts if needed. 

Using data from a sample of vehicles across the country, we can start to get a rough idea of how people are responding to this conflict. 

Comparing the two weeks pre-conflict in mid-February against 7-day rolling averages for subsequent weeks, we have seen a reduction of approximately 20% in the vehicle kilometres travelled by cars. Not necessarily surprising when petrol prices have gone up 30%. 

Also not surprising is that people are responding in a predictable way so far: they are using public transport more, with boardings up by more than 10% in Auckland and Wellington. MOT will be publishing updated data regularly, starting later today. 

Interestingly, last week saw more than 1,000 electric vehicles registered, close to double the week prior. This makes it the biggest week in EV registrations since the end of 2023. Year-to-date registrations are nearly 2,000 higher than this time last year.

Heavy vehicles are also down around 5% over the last few days, despite an increase of 70% in diesel prices. This is expected – those who rely on heavy vehicles for freight or commercial use have far less ability to respond to these kinds of price shocks with immediate alternatives. 

We know higher fuel prices are hitting families and businesses hard. That’s why we announced targeted cost-of-living relief for low- and middle-income families earlier this week.

From 7 April, about 143,000 working families with children will get an extra $50 a week through a boost to the in-work tax credit. 

The increase will be temporary, lasting for one year or until the price of 91 octane petrol drops below $3 a litre for four consecutive weeks. 

This boost will deliver support to working families who are under significant cost-of-living pressure, without driving inflation up higher or further driving up Government debt as this $373m initiative is being paid for out of Budget 2026 operating allowances.

The COVID-19 Inquiry stressed that spending in response to crises should be timely, targeted, and temporary. That is also what Treasury says.

That’s what we’re doing. 

The previous Government responded to COVID-19 through profligate, irresponsible spending – racking up debt. Some people have not learned from this and have called for this Government to make the same mistakes. But we won’t. 

Throwing the kitchen sink at every event that happens is a recipe for fiscal disaster. 

I understand the calls for broad, across the board, fuel tax cuts.

The government won’t be doing that, for a few reasons. 

One, as people here know, every dollar from petrol tax and RUC goes into the National Land Transport Fund, which funds our transport system.

Across the board fuel tax cuts are also extremely expensive, and they are untargeted.

We’d rather focus support on those who need it most.

The reality is that maintaining fuel supply is the most important thing we can do to protect Kiwis from the worst case scenarios.

Later today Nicola Willis – who is in charge of our response as a Government – will provide an update on the National Fuel Plan along with further detail around how we see some of the steps playing out in practice.

We all hope things improve quickly – but as the Prime Minister has said, hope is not a plan.

So, we’re doing the hard yards now to ensure New Zealand has a solid fuel plan that gets us through whatever the international situation throws at us in the coming months. 

Our Transport Funding Challenge

We have significant transport funding challenges.

I am determined to be upfront with the public about this.

Our transport system is supposed to be user pays. In other words, road users pay petrol tax and road user charges and the money goes out the other end on maintenance, upgrades and new projects.

But in recent years, Crown funding has been tipped in more and more, which comes from general taxation – in other words, all taxpayers.

The 2018-21 National Land Transport Programme outlined expenditure of $17 billion over 3 years, and was largely funded by road users, who contributed $13 billion.

Fast forward to the 2024-27 NLTP, and the total investment has nearly doubled at $32.9 billion, but road users are still contributing roughly the same amount, $14.3 billion.

The increased investment has come primarily from Crown funding, with around $12.8 billion of direct Crown funding provided over 2024-27.

Capital contributions from general taxation have to compete with every other important priority the government has to fund.

Every dollar of extra Crown capital we put into roading is a dollar that can’t go into health, or education, or defence, or any of the other calls on capital the Crown has.

Of course, all of these areas have significant deficits and similar funding challenges.

So that’s a real problem.

Then you add in all of the calls for transport investment.

We have real resilience challenges on our state highway network. The recent weather events on the East Coast have shone a spotlight on that.

We have significant deferred maintenance and renewal work required on the Wellington and Auckland metro rail network.

The country needs a second harbour crossing in Auckland.

City Rail Link will open later this year, and soon the conversation will turn to what the next big public transport project is in Auckland.

We have pipeline of Roads of National Significance, important growth-enhancing projects around the country.

So how do we make all of this add up?

One option is to lift petrol tax and RUC.

Petrol tax has not risen since 2020 and has not kept up with inflation. In 2023, we campaigned on not increasing petrol tax in our first term. This was the right thing to do when there was a cost of living crisis, but we have to be honest about those consequences. It has deferred the issue until later.

Petrol tax is currently due to go up by 12c per litre in 2027, by six cents on 1 January 2028, and 4 cents in each year after that.

I have to be honest with you, the idea that we would put up fuel tax during a fuel crisis seems like a non-starter to me.

I’m thinking hard about the funding challenge we’ve just laid out and I’ll have more to say soon.

Later this year we’ll publish a draft Government Policy Statement for Transport funding from 2027 onwards, which lays out how we intend to confront some of these challenges.

And we’re also intending to publish what I’ve been calling a Major Transport Projects Pipeline.

This is about building a credible, long-term pipeline of transport projects with a variety of funding options and in a logical sequence, so that when funding becomes available, the sector and the public knows what project is coming next, and can plan and prepare for it.

New funding tools

We are pushing forward with our reforms to increase the number of funding tools we have in the toolkit to deliver transport projects.

Last year, we introduced the Land Transport (Revenue) Amendment Bill to move towards a fairer, simpler, and more modern transport funding system.

The Bill introduces a more flexible tolling framework and enables simpler, technology-enabled ways to pay road user charges, so everyone pays their fair share for the roads they use.

At the heart of these reforms is fairness. Every road user should contribute in proportion to their use of the network.

Transition to RUC

Our road user charges system is outdated. It was designed in the 1970s and still relies on manual paperwork and paper licences.

Right now, drivers paying RUC have to track their odometer readings and stick paper labels to their windscreen.

The Bill opens the door for new payment models like subscriptions or post-payment, and allows private companies to offer easy, set-and-forget billing options – similar to how many of us already pay for power or streaming services.

The changes, to modernise the system, will also help us prepare for abolishing the fuel excise duty and transition everyone over to RUC.

The abolition of petrol tax, and the move towards all vehicles (whether they be petrol, diesel, electric or hybrid) paying for roads based on distance and weight, is the biggest change to how we fund our roading network in 50 years.

As our vehicle fleet changes, so too must the way we fund our roads. It isn’t fair to have Kiwis who drive less and who can’t afford a fuel-efficient car paying more than people who can afford one and drive more often.

The Government’s plan will eventually see all vehicles pay based on actual road use (including weight) regardless of fuel type.

Tolling

On tolling, we are giving ourselves the flexibility to deliver the big projects New Zealand needs, sooner.

Tolling is a key tool for bringing forward investment, and the Bill introduces a number of changes.

Enabling corridor tolling will allow tolling on parts of an existing road where users clearly benefit from a new project in the same corridor.

The Bill gives us new tools to manage diversion from toll roads, including restricting heavy vehicles from unsuitable alternative routes like they do overseas, and allowing toll revenue to help maintain those alternative routes when councils can’t.

We are also introducing annual CPI adjustments to make tolling fairer and more predictable, as well as shifting liability from the driver to the registered person to improve collection efficiency.

Time of Use Charging

Other legislation passed last year gives local authorities the tools to tackle the problem of congestion.

Sitting in traffic wastes time, costs money, and drags down productivity. 

Our three largest cities are significantly more congested than comparable Australian cities with similar population sizes and densities, with Auckland congestion alone estimated to cost up to $2.6 billion by 2026.

Time-of-use charging is a commonsense tool to encourage people to travel at off-peak times or by other modes. It’s about keeping our cities moving.

The legislation allows local authorities to partner with NZTA on targeted time-of-use schemes to ease gridlock, improve travel time reliability, and support economic growth.

Auckland Council is well advanced in shortlisting scheme design options and the Ministry of Transport and NZTA officials are supporting them with implementation planning.

Road safety 

Finally, I want to spend a moment on what we’re seeing in road safety outcomes, and what’s sitting behind them.

Road deaths have trended down since 2022. In 2024, there were 292 deaths and 2,461 serious injuries on our roads. That’s good progress, and it matters. 

But we need to be careful not to draw simple conclusions from complex data. No single factor explains year‑to‑year changes in deaths and serious injuries, and it’s still too early to say whether this represents a long‑term downward trend.

What we do know is that the biggest gains come when we focus on the highest‑risk behaviours and invest in proven, cost‑effective interventions. 

That’s exactly what the Road Safety Objectives are designed to do — with a clear focus on the main contributors to fatal crashes, including alcohol and drugs.

Enforcement is a critical part of that picture. The Government has invested a record $1.335 billion over three years, from 2024 to 2027, into the Road Policing Investment Programme. That funding supports frontline policing and enforcement activity, particularly during high‑risk times. 

 

Each year, the programme targets 3.3 million passive breath tests and breath screening tests, with more than two million of those carried out when risk is highest. 

Importantly, funding is also ring‑fenced for 50,000 roadside oral fluid drug tests each year from the first year of implementation.

I also want to share what we’re hearing directly from Police as roadside drug testing beds in.

Since testing was introduced across the Wellington region in December, Police have been gaining valuable operational insight into how this new road safety tool works in practice. 

Testing has been carried out right across the district — from Wellington central through to the Wairarapa and Kapiti — and that experience is already shaping how the national rollout will be delivered.

As of 18 March, Police have conducted more than 650 roadside drug screening tests, resulting in 24 positive tests. The positivity rate at the roadside is broadly in line with what Police see for alcohol.

While it’s still too early to draw conclusions about national trends, Police have seen an increase in positive results as testing activity has expanded across Wellington.

Importantly, officers report favourable feedback from the public during testing. Police are continuing to collect data, but at this early stage the focus is on learning, refining processes, and getting ready.

Feedback from frontline staff has been positive, with Police telling us they are geared up and ready to support the nationwide rollout, with testing across New Zealand by mid‑2026.

But enforcement alone isn’t enough. The Road Safety Objectives also focus on improving the safety of the roads themselves. As the recent AA research report points out, where we have made significant investment in improving the roads we see the benefits of reduced deaths and serious injuries.

Vehicles are another important piece of the puzzle. The overall safety of New Zealand’s has continued to improve over time. In 2025 alone, there were nearly 40,000 fewer one‑ and two‑star vehicles on the road.

Alcohol interlocks 

Finally, we’re looking closely at what works for repeat high‑risk offenders. One key, underutilised, tool here is alcohol interlocks. 

A recent Ministry of Transport study using the Integrated Data Infrastructure database affirms that alcohol interlocks reduce the risk of alcohol-impaired driving.  

Here’s some very interesting data. 

Drink-driving offenders given alcohol interlock orders are:  

  • 9% less likely to reoffend within four years,
  • 45% more likely to remain in employment, and
  • 22% less likely to depend on welfare than comparable drink-drivers given driving disqualification orders. 

It’s clear that alcohol interlocks are effective when they’re installed and used properly.  

Despite their effectiveness, the uptake of alcohol interlocks is lower than it could – and frankly should – be. Many eligible offenders are not given alcohol interlock sentences, and many offenders who are ordered to get alcohol interlock devices do not do so. 

I am actively investigating how to increase the uptake of interlocks with Paul Goldsmith, the Minister of Justice.

Tackling New Zealand’s toughest road safety challenges means focusing on what works and making sure it’s used as effectively as possible.

Conclusion

Thank you for listening and I welcome any questions you have.

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/27/speech-to-the-automobile-association-annual-conference/

Posted on

InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit

Source: Media Outreach

BEIJING, CHINA – EQS Newswire – 26 March 2025 – InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the annual results for 2025 as of December 13, 2025.

2025 marked InnoCare’s 10th anniversary and a milestone year of transformative growth and strategic execution. The Company achieved its first full year profitability, secured two new drug application (NDA) approvals, enhanced market penetration of its core products, accelerated globalization, and made breakthroughs across multiple pipelines. With numerous “China First” achievements, InnoCare continues to accelerate its 2.0 development strategy, demonstrating its strong ability to translate scientific innovations into sustainable long-term growth.

Financial Highlights

  • Revenue grew 135.3% year-on-year to RMB 2,375 million[1] in 2025, mainly driven by robust commercial growth and two strategic business development (BD) deals.
  • Profit reached RMB 644 million, achieving profitability for the first time, mainly due to significant commercialization growth and global out-licensing deals.
  • Gross Profit Margin increased by 5.7 percentage points to 92%.
  • Research and Development Investment increased by 16.9% to RMB 952 million in 2025, reflecting advancements of multiple Phase III registrational trials, as well as increased investments in new technology platforms such as ADCs and molecular glue.
  • Cash and Related Accounts Balance[2] stood at approximately RMB 7.8 billion as of December 31, 2025 and achieved positive operating cash flow for the first time. This strong cash position provides InnoCare with the flexibility to expedite global clinical development of key assets and invest in new technology platforms.

Accelerating Globalization with Transformative Deals

In 2025, InnoCare accelerated the implementation of its globalization strategy, unlocking global value of its core pipeline with two out-licensing deals, further enhancing the Company’s global influence and financial performance, and marking a significant step forward in its global expansion.

On Oct. 8, InnoCare entered into a transformative licensing agreement with Zenas for its autoimmune disease pipeline, including orelabrutinib. The agreement includes up to US$100 million in upfront and near-term milestone payments, and up to 7,000,000 shares of Zenas common stock, with a total deal value exceeding US$ 2 billion, setting a new record for small molecule autoimmune out-licensing in China.

This strategic collaboration marks a significant milestone in InnoCare’s globalization journey and will leverage shared focus to accelerate the global Phase III clinical development of orelabrutinib for the treatment of primary progressive multiple sclerosis (PPMS) and secondary progressive multiple sclerosis (SPMS), maximizing its clinical and commercial value worldwide, and advance a novel oral IL-17 AA/AF inhibitor and a brain-penetrant oral TYK2 inhibitor into clinical trials.

In addition, InnoCare entered into a licensing agreement with Prolium to further its global presence in 2025. In March 2026, Prolium announced first dosing of healthy volunteers in an ongoing single ascending dose study of ICP-B02 (PRO-203) and expects to initiate a multinational Phase I/II study of ICP-B02 in systemic sclerosis (SSc) in the second quarter of 2026, with additional studies in B-cell-driven autoimmune disease expected to follow.

Dr. Jasmine Cui, the Co-founder, Chairwoman, and CEO of InnoCare, said, “Building on an inspiring decade of solid growth, we have continuously enhanced our fully integrated platform ranging from original innovation, clinical development, commercialization, manufacturing, to business development, achieving our strategic goal of break-even ahead of schedule, marking a significant milestone in our development history. As we enter our 2.0 phase of rapid development, we are focused on key strategic priorities, including securing approvals for five to six innovative drugs, advancing three to four products globally, and progressing five to ten differentiated molecules into clinical trials. We will further accelerate globalization, significantly increase revenue, and deliver more high-quality innovative therapies to benefit patients worldwide. “

Building A Leading Franchise in Hemato-Oncology

In 2025, InnoCare made significant progress toward building a leading hemato-oncology franchise, driven by advances in commercial execution, late-stage clinical development, and global expansion.

InnoCare continued to strengthen its commercial portfolio with orelabrutinib approved for first line chronic lymphocytic leukemia/small lymphocytic lymphoma (1L CLL/SLL) and successfully included in the updated National Reimbursement Drug List (NRDL), while tafasitamab became the first CD19 antibody approved for the treatment of relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) in China. As a result, drug sales increased by 43.4% to RMB 1,442 million in 2025.

Mesutoclax (ICP-248), the first BCL2 inhibitor granted Breakthrough Therapy Designation in China, continues to advance across multiple indications, including CLL/SLL, mantle cell lymphoma (MCL), acute myeloid leukemia (AML), and myelodysplastic syndromes (MDS), with clinical trials ongoing in China and globally. Together, these three assets form the core of InnoCare’s hemato-oncology strategy, supporting near-term revenue growth with a pipeline of differentiated, late-stage therapies.

Orelabrutinib

Orelabrutinib serves as a backbone therapy in InnoCare’s extensive hemato-oncology pipeline. Its newly approved 1L CLL/SLL indication has been included in the NRDL and is recommended as a Class I treatment in the Chinese Society of Clinical Oncology (CSCO) Diagnosis and Treatment Guidelines for Malignant Lymphoma. With all four approved indications now covered under the NRDL, orelabrutinib offers stable annual treatment costs, benefiting more lymphoma patients.

The commercial team further strengthened execution capabilities and sharpened strategic focus, delivering strong sales performance throughout 2025. Improved market penetration and operational discipline laid a solid foundation for sustained revenue growth and long-term commercial success.

Internationally, orelabrutinib continued to expand its regulatory footprint, with approval granted for relapsed or refractory marginal zone lymphoma (R/R MZL) in Singapore and NDA submission for R/R MCL successfully completed in Australia.

Tafasitamab

In May 2025, the tafasitamab regimen received NDA approval for adult patients with R/R DLBCL, representing the first CD19 antibody therapy approved in China for this indication and a key addition to InnoCare’s commercial portfolio.

Building on the initial commercial launch in September 2025, 2026 will mark the first full year of tafasitamab sales in China. Moreover, tafasitamab has been included as a Class II recommendation in the CSCO Guidelines, which will help address unmet clinical needs in this patient population and provide meaningful benefits.

Mesutoclax (ICP-248)

As the first BCL2 inhibitor granted BTD in China, mesutoclax has rapidly advanced across multiple registrational studies. The Phase III combination regimen with orelabrutinib for 1L CLL/SLL completed patient enrollment within 10 months, demonstrating strong clinical execution. This fixed-duration combination regimen has the potential to deliver deeper remissions, bringing hope for clinical cure and representing a promising treatment option.

A registrational trial in BTK inhibitor-treated MCL is progressing rapidly, and a Phase III randomized, double-blind, multicenter study of mesutoclax in combination with orelabrutinib versus pirtobrutinib (a reversible BTK inhibitor) in r/r MCL is expected to commence in 2026.

Global development of mesutoclax in AML and MDS is progressing across China, U.S., and Australia. The global AML and MDS markets are projected to reach US$8 billion[3] and US$11 billion[4] by 2034 respectively.

Mesutoclax, as a monotherapy or in combination with orelabrutinib, demonstrated a favorable safety profile for CLL/SLL across all dose levels tested. In the CLL/SLL patients receiving mesutoclax in combination with orelabrutinib, the overall response rate (ORR) was 100%, the complete response rate (CRR) was 57.1%, and the peripheral blood uMRD rate at 36-week was 65%. The clinical data from mesutoclax monotherapy demonstrated potential best in class efficacy in MCL patients, particularly in heavily treated patients with BTK inhibitor refractory. Among MCL patients who were BTK inhibitor-refractory, the ORR was 84.0% and the CRR was 36.0%. Mesutoclax in combination with orelabrutinib demonstrated a consistently favorable safety profile across B-cell malignancies (MCL, MZL, CLL/SLL). This oral, chemo-free regimen has the potential to establish a novel therapeutic option for B-NHLs. Updated data will be presented at 2026 American Society of Clinical Oncology (ASCO) annual meeting.

The combination of mesutoclax and azacitidine demonstrated a favorable safety profile and encouraging anti-tumor activity not only in AML but also in MDS patients. Among 35 evaluable treatment-naive AML patients, the regimen achieved an 85.7% composite CR rate and an 86.7% uMRD rate, with no mortality observed with 90 days. Preliminary data among MDS patients is also promising. There were no dose-limiting toxicities (DLT) or tumor lysis syndrome (TLS) events. Detailed data to be presented at 2026 ASCO annual meeting.

Developing B-cell and T-cell Pathways in Autoimmune Diseases

Autoimmune diseases can affect almost every organ in the body and may arise at any stage of life. The global market for autoimmune disease therapeutics is anticipated to reach $185 billion by 2029[5]. The Company has fortified its powerful discovery engine on cutting-edge global targets for the development of autoimmune therapeutics through B-cell and T-cell pathways, with the aim of delivering first-in-class and/or best-in-class treatments to address the massive unmet clinical needs and strong market potential in China and globally.

Orelabrutinib

Immune Thrombocytopenia (ITP): With over 200,000 new cases globally each year, including 60,000 in China, ITP represents a significant unmet medical need. The pivotal Phase III study has been completed, and the Company expects to submit the NDA application in the first half of 2026. ITP represents an important expansion of orelabrutinib from hematologic malignancies into autoimmune hematologic diseases, unlocking its enormous commercial potential. By leveraging the BTK inhibitor’s advantage in ITP, such as decreased macrophage-mediate platelet destruction and reduced production of pathogenic autoantibodies, orelabrutinib is well positioned to become a preferred BTK inhibitor in the field of ITP.

Systemic lupus erythematosus (SLE): There are about 8 million SLE patients worldwide. Orelabrutinib is the first BTK inhibitor to demonstrate significant efficacy in a Phase II clinical trial for SLE. The Phase IIb study met its primary endpoint, and a Phase III registrational study was initiated in the first quarter of 2026. Under stringent steroid-tapering requirements, orelabrutinib 75 mg once daily (QD) achieved a statistically significant improvement in SLE Response Index-4 (SRI-4) rate compared with placebo at Week 48 (57.1% vs. 34.4%, p

Multiple Sclerosis (MS): The US SPMS and PPMS market exceeds US$12 billion[6], representing a significant commercial opportunity. Based on the deal, InnoCare has been cooperating with Zenas to accelerate two global Phase III clinical trials of orelabrutinib for the treatment of PPMS and SPMS, further unleashing its global value in autoimmune diseases.

  • Initiated Orelabrutinib PriMroSe PPMS trial, a Phase III, global registration-directed, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of orelabrutinib in patients with PPMS in the third quarter of 2025. More information on the Phase III PriMroSe trial (NCT07067463) is available at clinicaltrials.gov.
  • Orelabrutinib Monarch trial for non-active SPMS (naSPMS) is planned, a Phase III, global registration-directed, multicenter, randomized, double-blind, placebo-controlled trial to evaluate the efficacy and safety of orelabrutinib in patients with naSPMS is expected to initiate in the first quarter of 2026. More information on the Phase III Monarch trial (NCT07299019) is available at clinicaltrials.gov.

Two TYK2 Inhibitors

The global dermatology drug market has enormous potential, with over 500 million patients suffering from dermatological diseases worldwide. By 2035, the global dermatology market size is projected to reach nearly US$100 billion. InnoCare is well positioned to capture this opportunity with two TYK2 inhibitors targeting multiple high-value indications, including atopic dermatitis (AD), psoriasis, vitiligo, nodular prurigo (PN), urticaria (CSU), cutaneous lupus erythematosus (CLE), and other dermatological diseases. The global AD market is projected to reach $30 billion[7] by 2030, the vitiligo market $3 billion[8] by 2032, the CSU market $3 billion[9] by 2029, the psoriasis market $58 billion[10] by 2032, the PN market $3 billion[11] by 2034, and CLE market US$ 7.9 billion[12] by 2032.

Soficitinib (ICP-332)

The Phase III clinical study of soficitinib in patients with moderate to severe atopic dermatitis (AD) completed patient enrollment, with data readout expected in mid-2026. The Phase II clinical study of soficitinib in patients with vitiligo has also completed patient enrollment. Additional studies in prurigo nodular, urticaria, and psoriasis are progressing rapidly. As a result, soficitinib is expected to deliver a series of clinically meaningful data catalysts in 2026.

Data from the Phase II clinical trial of soficitinib in patients with moderate-to-severe AD were published in JAMA Dermatology in January 2026. The journal concluded that soficitinib demonstrated a favorable safety profile and encouraging efficacy in patients with AD.

Soficitinib achieved multiple efficacy endpoints in the study. The percentage improvement from baseline in EASI at Week 4 were 78.2% in the soficitinib 80 mg group, 72.5% in the soficitinib 120 mg group, and 16.7% for those receiving placebo. There was a statistically significant higher EASI-75 response rate with both soficitinib doses (64.0% for each; difference vs placebo, 56.0%) than with placebo and a greater percentage of Validated Investigator Global Assessment for Atopic Dermatitis (vIGA) score of 0 or 1 and improvement of 2 or more points at Week 4 in the soficitinib 80 mg group vs placebo (36.0%; difference vs placebo, 32.0%, P=0.005). Meanwhile, soficitinib demonstrated rapid relief of pruritus and significant improvement in quality of life. Substantial reductions in Pruritus NRS severity and frequency scores were observed on Day 2 of treatment compared to placebo, with continued improvement over time, peaking at Week 4 for both severity and frequency (all P

ICP-488

The Phase III clinical study in psoriasis has completed patient enrollment, and the Phase II trial for CLE is progressing rapidly. The IND for Sjögren’s syndrome has been submitted, and additional indications and combination strategies are under evaluation.

Data on ICP-488 for the treatment of patients with moderate-to-severe plaque psoriasis has been released at the 2025 AAD Annual Meeting as a late-breaking oral presentation. The study results demonstrated that ICP-488 is highly effective in treating psoriasis at both the 6 mg QD and 9 mg QD doses. Moreover, ICP-488 exhibited favorable safety and tolerability profiles, reinforcing its potential as a valuable treatment option for moderate-to-severe psoriasis patients.

At week 12, the percentage of patients achieving PASI 75 was significantly superior in the ICP-488 6 mg QD group (77.3%) and the 9 mg QD group (78.6%) than that of the placebo group (11.6%); the percentages of subjects achieving PASI 90 and sPGA of 0 (clear) or 1 (almost clear) were also significantly higher in the ICP-488 6 mg QD group (36.4%, 70.5%) and 9 mg QD group (50.0%, 71.4%) compared to the placebo group (0%, 9.3%).

ICP-538

The first healthy volunteer has been dosed in a clinical trial of ICP-538, a VAV1-directed molecular glue degrader (MGD), in China. This is the first VAV1 degrader approved to enter clinical trials in China. ICP-538 is a novel, potent, highly selective, orally administered molecular glue degrader targeting VAV1, a key protein downstream of T-cell and B-cell receptors. ICP-538 induces rapid and efficient degradation of the VAV1 protein in a dose-dependent manner by selectively mediating the formation of a ternary complex between the CRBN E3 ubiquitin ligase and the VAV1 protein. ICP-538 will be developed for the treatment of autoimmune diseases, such as inflammatory bowel disease, systemic lupus erythematosus, and multiple sclerosis. Currently, there are no approved VAV1-targeted therapies globally.

ICP-054

The IND application of ICP-054 (ZB021), a novel oral IL-17AA/AF inhibitor, was submitted. ICP-054 is a novel, oral, highly potent and selective IL-17AA/AF inhibitor with significant therapeutic potential in autoimmune and inflammatory diseases. ICP-054 can effectively block the signal transduction pathways of IL-17AA homodimer and IL-17AF heterodimer, thereby inhibiting the release of pro-inflammatory cytokines and chemokines, exerting an anti-inflammatory effect. Simultaneously, it reduces excessive proliferation of keratinocytes and inflammatory cell infiltration, improving skin lesions and thus suppressing the occurrence of autoimmune and inflammatory diseases.

Under the BD agreement, Zenas holds exclusive rights to develop, manufacture and commercialize the oral, IL-17AA/AF inhibitor in all territories outside Greater China and Southeast Asia.

Building Innovative Solid Tumor Assets

InnoCare has been building a robust and diversified portfolio to address significant unmet medical needs across multiple tumor types. The Company is committed to combining targeted small molecules with next-generation antibody-drug conjugates (ADCs) to maximize clinical benefit while minimizing systemic toxicity. The R&D team aims to focus on tumor types with high unmet needs, and to develop therapies that are differentiated in mechanism of action, potency, and safety profile. InnoCare’s proprietary ADC technology platform, alongside promising precision medicine candidates like zurletrectinib, positions the Company to establish a strong presence in the field of solid tumor treatment.

Zurletrectinib (ICP-723)

Zurletrectinib, a next generation TRK inhibitor, represents InnoCare’s first approved therapy in solid tumors and its third innovative product approved for marketing. Zurletrectinib is indicated for adult and adolescent patients (12–18 years) with NTRK gene fusion-positive tumors.

In the registrational clinical trial for patients with NTRK fusion-positive solid tumors, zurletrectinib demonstrated outstanding efficacy and a favorable safety profile. The study results showed an ORR of 89.1%, a disease control rate (DCR) of 96.4%, and 24-month progression-free survival (PFS) and overall survival (OS) rates of 77.4% and 90.8% respectively.

InnoCare expects to submit NDA for pediatric patients (2 years

In-House Developed Antibody-Drug Conjugate (ADC) Platform

The Company has developed a cutting-edge ADC platform with proprietary linker-payload (LP) technologies, aimed at the delivery of potent and targeted therapies for cancer treatment. This platform allows for the creation of highly differentiated ADCs with improved efficacy and safety profiles. Key features of the platform include:

  • Irreversible bioconjugation: ensuring stable antibody-linker bioconjugation for improved stability.
  • Hydrophilic linker: enhancing ADC stability and achieving a high drug-to-antibody ratio (DAR) of 8.
  • Novel payload: incorporating highly potent cytotoxic payloads with a strong bystander killing effect.

The platform is expected to deliver ADCs with strong tumor-killing efficacy and an adequate therapeutic window, thereby broadening treatment options for cancer patients and improving their clinical outcomes. As the platform continues to evolve, the Company is poised to expand its portfolio with multiple differentiated ADC candidates, further advancing precision medicine in oncology.

ICP-B794: A Novel B7-H3 Targeted ADC for Solid Tumors

InnoCare is advancing the Phase I dose escalation trial of novel B7-H3 targeted ADC, ICP-B794. ICP-B794 is a novel ADC comprising a humanized anti-B7-H3 monoclonal antibody conjugated to a potent in-house developed payload via a protease-cleavable linker. This combination ensures precise targeting of tumor cells while minimizing off-target effects, offering a promising treatment for solid tumors such as lung cancer, esophageal cancer, nasopharyngeal cancer, head and neck squamous cell carcinomas, prostate cancer, and others. ICP-B794 has demonstrated superior anti-tumor activity in animal models compared with other ADCs, and exhibited significant tumor-killing effects even in large tumors.

Early clinical observations indicate favorable pharmacokinetics and tolerability, with preliminary signs of antitumor activity, which validate the Company’s proprietary ADC platform for solid tumor development.

ICP-B208: A Novel CDH17 Targeted ADC for Solid Tumors

Building on the encouraging efficacy and safety of ICP-B794, the second ADC candidate, ICP-B208, is designed to target CDH17, a calcium-dependent cell adhesion protein that plays a key role in tumor cell proliferation, migration, and metastasis. Its tumor-restricted expression and functional role in cancer biology make CDH17 an attractive and differentiated target for ADC therapy, enabling the delivery of potent cytotoxic payloads specifically to tumor cells while minimizing systemic toxicity, which can be developed for the treatment of gastrointestinal cancers, including gastric, colorectal, pancreatic ductal adenocarcinoma, and cholangiocarcinoma. Preclinical studies show that ICP-B208 demonstrates good anti-tumor activity even in CDH17-low tumors. The IND application has been submitted in March 2026.

InnoCare plans to submit at least two more ADC INDs within 2026, further expanding its differentiated solid tumor pipeline.

To know more about the detailed financial data and business updates of InnoCare 2025 annual results, please log in to https://www.innocarepharma.com/en/investor/home .

Conference Call Information

InnoCare will host a conference call at 8:30 p.m. Beijing time on March 25 in English and at 9:00 a.m. Beijing time in Chinese on March 26, 2025. Participants must register in advance of the conference call. Details are as follows:

For English conference call, please register through the below link:
https://goldmansachs.zoom.us/webinar/register/WN_rVCbaOqMSM-QJQlfzlTEvw

For Chinese conference call, please register through the below link:
https://s.comein.cn/qz7duugd

Forward-looking Statement

This report contains the disclosure of some forward-looking statements. Except for statements of facts, all other statements can be regarded as forward-looking statements, that is, about our or our management’s intentions, plans, beliefs, or expectations that will or may occur in the future. Such statements are assumptions and estimates made by our management based on its experience and knowledge of historical trends, current conditions, expected future development and other related factors. This forward-looking statement does not guarantee future performance, and actual results, development and business decisions may not match the expectations of the forward-looking statement. Our forward-looking statements are also subject to a large number of risks and uncertainties, which may affect our short-term and long-term performance.

[1] The financial figures in this article are based on Hong Kong Financial Reporting Standards

[2] Include cash and bank balances, other current assets, financial assets among other non-current assets, and interest receivable

[3] Global Growth Insights

[4] Nova One Advisor, Insight Code: 8817

[5] iHealthcareAnalyst, Inc., Oct. 3, 2023

[6] Zenas estimate based on reported prevalence and current pricing of B cell therapies approved for MS

[7] Grand View Research

[8] Data Bridge Market Research

[9] The Business Research Company

[10] Fortune Business Insights

[11] Global Market Insights

[12] Data Bridge Market Research

Hashtag: #InnoCare

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/26/innocare-releases-2025-results-and-business-highlights-achieving-first-annual-profit/

Posted on

NZ-AU: Innovation Beverage Group Ltd. Announces Acquisition of Controlling Interest in BlockFuel Energy Inc. and Execution of Amended Merger Agreement

Source: GlobeNewswire (MIL-NZ-AU)

IBG Acquires 51% stake in BlockFuel Energy as business combination nears completion

Once complete, the combined entity will become a rising oil producer and power generation company with near-term production and scalable growth strategy

SYDNEY, March 25, 2026 (GLOBE NEWSWIRE) — Innovation Beverage Group Ltd (“IBG” or the “Company”) (Nasdaq: IBG), an innovative developer, manufacturer, and marketer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands, today announced that it has acquired a controlling interest in BlockFuel Energy Inc. (“BFE”), a Texas-based energy corporation. This transaction represents a significant milestone towards the proposed merger between both companies, which they anticipate closing in the coming weeks.

On March 16, 2026, IBG entered into a Share Exchange Agreement with certain shareholders of BFE pursuant to which IBG acquired 127,628 shares of BFE common stock, representing approximately 51% of BFE’s outstanding equity. As consideration for those shares, IBG issued warrants to purchase an aggregate of 3,815,766 ordinary shares of IBG at an exercise price of $0.0001 per share, which are not exercisable until shareholder approval and approval by The Nasdaq Stock Market LLC are obtained. The warrant shares represent 45.9% of the issued and outstanding shares of IBG and will represent 51% of the Merger Consideration payable at the time of the closing of the merger. Upon the consummation of the proposed merger between IBG and BFE, the warrants will be automatically adjusted to an aggregate of 20,643,297 ordinary shares of IBG and will be deemed exercised.

As part of the transaction, IBG also provided BFE with a $2.5 million unsecured loan, which facilitated the repurchase and cancellation of certain outstanding BFE shares. Following the closing of the previously announced merger, this loan will convert into an intercompany balance within the combined organization, further consolidating IBG’s ownership position.

Concurrently, IBG, BFE, and IBG’s wholly owned subsidiary, InnoBev Merger Corp., entered into an Amended and Restated Agreement and Plan of Merger. Upon completion of the proposed merger, BFE will become a wholly owned subsidiary of IBG and BFE equity holders are expected to own approximately 90% of the combined company, with IBG’s existing shareholders owning approximately 10%, subject to customary adjustments and dilution.

Strategic Transformation Nearing Completion

The transaction represents a strategic expansion of IBG into the energy and high-powered computing sectors. BFE focuses on the acquisition and development of oil and gas assets and the conversion of underutilized natural gas into electricity to power high-performance computing operations. BFE operates primarily in the United States, including Oklahoma, and is developing a vertically integrated platform combining energy production, power generation, and data centers.

Upon completion of the merger, the combined company is expected to operate under the BlockFuel Energy name, with IBG’s existing beverage business transitioning into an Australian-based subsidiary led by IBG’s CEO Sahil Beri as President. The new parent company will focus on scaling its U.S. onshore oil and gas operations.

“Completing the acquisition of a controlling interest in BlockFuel Energy advances our strategic transition and brings the merger closer to completion,” said Sahil Beri, Chief Executive Officer of Innovation Beverage Group. “We are positioning IBG for long-term growth by focusing on energy assets with strong fundamentals and near-term production potential, while maintaining our beverage business as a distinct subsidiary.”

“This transaction marks a significant step in building a scalable, U.S.-focused energy platform,” said Daniel Lanskey, Chief Executive Officer of BlockFuel Energy. “With a strengthened capital structure and aligned ownership, we are focused on advancing production and expanding our asset base as we begin operations.”

Building a Scalable U.S. Energy Platform

BlockFuel Energy is focused on the acquisition, development, and operation of oil and gas assets, with current operations primarily located in the United States, including acreage positions in Oklahoma.

The transaction provides IBG with immediate exposure to producing and development-stage energy assets, positioning the Company to pursue near-term revenue generation and long-term asset growth.

Based on preliminary engineering and comparable field deployments, BFE management believes onsite gas-to-power costs could be meaningfully below grid-based power pricing, while avoiding transportation, processing, and third-party power costs.

The acquisition was completed in connection with an amended and restated merger agreement between IBG and BFE. The closing of the full merger remains subject to customary conditions, including regulatory approvals and approval by The Nasdaq Stock Market LLC.

About Innovation Beverage Group Ltd

Innovation Beverage Group is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands for which it owns exclusive manufacturing rights. Focused on premium and super premium brands and market categories where it can disrupt age old brands, IBG’s brands include Australian Bitters, BITTERTALES, Drummerboy Spirits, Twisted Shaker, and more. IBG’s most successful brand to date is Australian Bitters, which is a well-established and favored bitters brand in Australia. Established in 2018, IBG’s headquarters, manufacturing and flavor innovation center are located in Sydney, Australia with a U.S. sales office located in California. For more information visit: https://www.innovationbev.com/.

About BlockFuel Energy

BlockFuel Energy is involved in the acquisition, exploration and development of proven oil fields onshore in North America. BlockFuel Energy combines state-of-the-art power generation with oil and gas exploration to power high-performance data centers. Our vertically integrated concept allows us to use co-location and modular power generation techniques to optimize efficiency and investment returns. Our cutting-edge solutions for energy optimization and extraction will enable us to transform underdeveloped resources into high-margin, scalable, and sustainable revenue streams. For more information visit: https://blockfuelenergy.com/.

Forward Looking Statement

This press release contains “forward-looking statements” within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the proposed merger between IBG and BlockFuel Energy, anticipated operational milestones, expected production levels, anticipated oil and gas sales, planned financing activities, expected economic benefits of such activities, and the proposed acquisition of additional oil field assets.

Forward-looking statements are typically identified by words such as “expects,” “anticipates,” “plans,” “projects,” “intends,” “believes,” “may,” “will,” “could,” “should,” or similar expressions. These statements are based on current expectations and assumptions and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks include, among others, the ability of the parties to execute definitive transaction documents, satisfy closing conditions, obtain regulatory and stockholder approvals, commodity price volatility, operational risks, financing risks, , and other risks described in IBG’s filings with the U.S. Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on these forward-looking statements. Neither IBG nor BFE undertakes any obligation to update such statements except as required by law.

Contact:

Innovation Beverage Group Limited
Sahil Beri
CEO
sahil@innovationbev.com
www.innovationbev.com

BlockFuel Energy Inc.
Daniel Lanskey
President and CEO
dan.lanskey@blockfuelenergy.com
www.blockfuelenergy.com

Investor Relations:

KCSA Strategic Communications
Phil Carlson, Managing Director
BlockFuel@KCSA.com

– Published by The MIL Network

LiveNews: https://livenews.co.nz/2026/03/26/nz-au-innovation-beverage-group-ltd-announces-acquisition-of-controlling-interest-in-blockfuel-energy-inc-and-execution-of-amended-merger-agreement/

Posted on

$50 a week for lower-income working families

Source: New Zealand Government

The Government is moving quickly to provide extra support for low-to-middle-income working families as conflict in the Middle East drives up fuel prices and adds pressure to household budgets.

From 7 April, about 143,000 working families with children will get an extra $50 a week through a boost to the in-work tax credit. The boost will also expand eligibility to around 14,000 additional working families, who will receive the tax credit at an abated rate.  

The increase will be temporary, lasting for one year or until the price of 91 octane petrol drops below $3 a litre for four consecutive weeks. 

“This temporary boost will deliver support to working families who are under significant cost-of-living pressure, without making inflation worse or further driving up Government debt,” Nicola Willis says.

“The policy is carefully targeted to families in the squeezed middle – parents who are working hard for a living, are not eligible for main benefits, and yet have modest household incomes with which to support their children. We know these families will be hit particularly hard by the global fuel-price shock. We are delivering them timely relief. 

“The Government will implement these changes at pace. Tomorrow we will introduce an Amendment Paper to the Taxation Bill currently before Parliament, so these changes can be enacted from 1 April.

“Most eligible households will not need to do anything to receive the increase. It will be paid directly into their bank accounts, starting on 7 April if they are paid weekly, and 14 April if they are paid fortnightly. 

“We are very aware that almost all Kiwi businesses and families are feeling price pressures as a result of the global shockwaves hitting New Zealand, but equally we know that responding with large, untargeted Government spending programmes could make things worse for Kiwis by adding more pressure to inflation and debt. We are making careful choices in order to protect New Zealand’s economic future. 

“The Government is conscious that a careless response to this crisis could have long-lasting and painful consequences. We saw this in the aftermath of Covid, where excessive spending more than doubled debt and sent inflation soaring and mortgage rates skyrocketing. Kiwis are still grappling with the effects of that today.

“That is why we are focused on temporary, timely support that is targeted to the workers who need it most, while continuing to manage the public finances carefully. 

“The policy is estimated to cost a one-off $373 million if it runs for the full year and less if it does not. There is no ongoing cost in future years because the change is time-limited. 

The cost will count against the Government’s operating allowance for the 2026 Budget so has already been factored into the Treasury’s fiscal forecast.

“Funding the policy this way will not add to forecast debt or inflationary pressures. It is consistent with the Government’s fiscal strategy which seeks to balance the books and bend the debt curve down.

“We cannot control global oil markets or international conflicts.

“But we can soften the impact on working families who cannot easily avoid higher fuel costs by delivering support in a responsible and well-targeted way.”

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/24/50-a-week-for-lower-income-working-families/

Posted on

Social Issues – Where is the support for benefit-dependent households? – CPAG

Source: Child Poverty Action Group

Child Poverty Action Group (CPAG) is calling for an increase to the Winter Energy Payment (WEP) to help offset the current surge in an already desperate cost of living crisis for families living on core benefits.
Minister Nicola Willis announced today that from April, 143,000 low-to-middle income families with working parents will receive $50 per week through the In-Work Tax Credit (IWTC).
CPAG spokesperson Isaac Gunson says while today’s announcement will alleviate some pressure in working families, there’s nothing for families relying on core benefits.
“Energy crises affect benefit-dependent families too. Where is their support?”
“Close to a quarter of a million children live in households receiving a core benefit. The idea that no additional support will be made available to that many tamariki is outrageous.”
“Christopher Luxon and Nicola Willis stood before the New Zealand public today and pointed to the automatic 3.1% inflation adjustment to core benefits on April 1 as the support they’re offering to benefit-dependent households. In the last three weeks, the cost of 91 petrol alone has climbed nearly 40%, and diesel by more than 80%.”
“Our Income Floor research clearly shows many of those incomes are already woefully inadequate to cover even the bare essentials, in a year where the cost of those essentials, like electricity, meat and poultry, and dairy products, rose faster than inflation.”
Programmes like the Winter Energy Payment (WEP), first announced in December 2017 and introduced the subsequent winter, made statistically significant reductions to two financial hardship measures during winter months, in households with working age recipients of a core benefit.
It is here CPAG believes support should be targeted.
Since it’s introduction in 2018, there has been no increase in the WEP rate, held at $20.46/week ($450.12 total) for single parents with no children and $31.82/week ($700.04 total) for couples and people with children.
Between December 2018 (after the first year’s payment concluded) and December 2025, household energy costs have increased 30%.
During the same period at the gas pump, 95, 91, and diesel have increased 31.3%, 31.8%, and 46.2%, respectively. (Source: Household Energy from SNZ CPI & Petrol from FigureNZ’s visualisation of MBIE data)
“CPAG is calling on the Government to increase the WEP by 30% in time for the coming winter. It’s an approach that aligns with the Government’s move to use already-established systems to support low-income families, but which also recognises the pain being felt in households receiving core benefits.”
This would lift the total WEP payment to $585.16 or $26.60/week for singles, and $910.52 or $41.37/week for couples or people with children.
We’d also ask the Government to consider extending the period of this year’s WEP to 26 weeks, starting in April, bringing the total WEP to $691.60 total for singles, or $1,075.62 total for couples or people with children.
“To shield New Zealand’s most vulnerable from the ripple effects of rising fuel costs, the Government should make its response a two-pronged approach: temporarily increase work-related tax credits and provide unconditional cash support to people on benefits through the WEP.”

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/24/social-issues-where-is-the-support-for-benefit-dependent-households-cpag/

Posted on

Greens Offer Votes To National Party For Immediate Relief In Fossil Fuel Crisis

Source: Green Party

The Green Party is offering its votes to the National Party to get on with passing a sensible and urgent fossil fuel crisis relief package. With the Greens’ and National’s combined 63 votes, no other political party’s support is necessary.

The Green’s proposed package includes:

  • Making public transport free for users;
  • A Relief Payment for low income people or people who live rurally to help meet additional transport costs;
  • A Windfall Profits Tax to prevent corporate price gouging;
  • Reversing changes to school bus eligibility and routes, and temporary expansion of eligibility for school buses;
  • Reversing the Government’s intended reduction in Total Mobility Support for disabled people; and
  • Increase mileage rates to the 23,000 care and support workers to meet their actual travel costs.

“We agree with the Prime Minister that hope is not a plan. That’s why the Green Party is presenting our plan to support our country through the fossil fuel crisis, targeting support to those who need it most, and reducing demand for petrol,” said Green Party Co-leader Chlöe Swarbrick.

“New Zealanders expect politicians to do everything we can to support people through this immediate crisis, and to minimise future vulnerability by reducing fossil fuel dependence. That’s why we have written to the Prime Minister and Minister of Finance offering our votes to make these obvious solutions a reality, urgently.

“Free public transport is a no-brainer. We remove the barriers to access, reduce congestion, and free up fuel supply for those who don’t have a public transport option.

“If the Government means what it says about ‘preparing for the worst’, now is the time to pull the plug on exorbitantly expensive, low-value projects like the Roads of National Significance and LNG import facility. The Green Party is ready, willing and able to provide the support necessary to invest in building real resilience through renewable energy generation.

“The Green Party’s Fossil Fuel Crisis Relief Payment would be targeted at adults earning under the median income and also people living rurally, where public transport is not available,” said Green Party Co-leader Marama Davidson.

“The Fossil Fuel Crisis Relief Payment will put money in the pockets of those being squeezed the hardest and those with few other transport options, easing stretched household budgets right now.”

“Petrol companies shouldn’t be unreasonably profiting from this or any economic crisis. A windfall tax would mean any exorbitant profits are redirected to our communities.”

“We need to ensure that corporations aren’t profiting while people in our communities who are struggling or have no alternative transport options pay the price. The Green’s package will provide immediate help for those who need it, reduce demand for petrol, and keep a check on corporate greed,” said Davidson.

Read the letter here.

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/23/greens-offer-votes-to-national-party-for-immediate-relief-in-fossil-fuel-crisis/

Posted on

RNZ-Reid Research poll: Labour extends lead over National

Source: Radio New Zealand

The latest poll numbers would leave NZ in limbo, producing 60 seats each for the coalition and opposition blocs. RNZ

National has slipped further behind Labour in the latest RNZ-Reid Research poll, falling to 30.8 percent support.

While a better result than the 28.4 percent it recorded in the most recent Taxpayers’ Union Curia poll, it still makes grim reading for Prime Minister Christopher Luxon, who has recorded his lowest personal approval rating yet.

If replicated on polling day, the numbers would leave the country in limbo, producing 60 seats each for the coalition and opposition blocs.

The poll, published Monday, puts Labour in the top spot on 35.6 percent, up 0.6 points from January, while National is down 1.1 points to 30.8 percent.

New Zealand First continues its upward trajectory, climbing 0.8 points to 10.6 percent, its highest score since July 2017.

The Greens are on 10.1 percent (up 0.5 points), ACT is on 7 percent (down 0.6 points), and Te Pāti Māori sits at 3.2 percent (up 0.2 points).

The poll surveyed 1000 eligible voters online between 12-20 March. Half of the respondents, however, were surveyed before 14 March, meaning the result won’t fully reflect the public response to the dispute between Labour leader Chris Hipkins and his ex-wife.

Undecided or non-voters made up 7.1 percent of those polled.

If the results were repeated at a general election, National would win 38 seats, NZ First 13 and ACT nine. On the left, Labour would bring in 44 MPs, the Greens 12 and Te Pati Māori four.

That would make a 60-60 deadlock in a 120-seat Parliament, likely sparking negotiations across the aisle to try secure a majority and prevent an election re-run.

The party vote is reflected in the preferred prime minister measure, with Hipkins leading on 20.7 percent, down 0.4 points.

Luxon has dropped 2.1 points to 17.3 percent, while NZ First leader Winston Peters sits at 13.1 percent, up 0.5 points.

More than 19 percent of voters declined to name a preferred prime minister.

Half of respondents – 50.4 percent – say Luxon is performing poorly as prime minister, compared with 29.8 percent who rate him well.

That gives Luxon a net score of -20.6 (down 6.6 points), his weakest result in the Reid Research series since becoming National leader in 2021. (Note: Reid Research did not run any public polls between November 2023 and March 2025.)

Former National leaders, however, received worse scores while in opposition: Judith Collins recorded a net rating as low as -37.9 in mid-2020 and Simon Bridges dropped to -39 in mid-2019.

Hipkins’ net performance score remains stronger, though it too is trending down.

With 35.9 percent rating him well and 35.6 percent poorly, his net rating has slipped to just 0.3 (down 0.6 points), also his lowest as Labour leader.

The poll also shows worsening public sentiment, with 50 percent (up 3.4 points) of respondents saying New Zealand is heading in the wrong direction, compared with 32.3 percent (down 4 points) who think it is on the right track

That gives a net score of -17.7, down 7.4 points from January.

About 16 percent of voters are undecided, while another 2 percent say they do not know.

National supporters are the most optimistic with a net score of +63.1, followed by ACT supporters on +24.1.

NZ First voters are much more pessimistic, recording a net score of -24.6.

This poll of 1000 people was conducted by Reid Research, using quota sampling and weighting to ensure representative cross section by age, gender and geography. The poll was conducted through online interviews between 12-20 March 2026 and has a maximum margin of error of +/- 3.1 percent at a 95 percent confidence level.

– Published by EveningReport.nz and AsiaPacificReport.nz, see: MIL OSI in partnership with Radio New Zealand

LiveNews: https://livenews.co.nz/2026/03/23/rnz-reid-research-poll-labour-extends-lead-over-national/

Posted on

Statement – Home support workers must be front of queue for fuel fix Nicola Willis – PSA

Source: PSA

The PSA is urging the Finance Minister to make 23,000 home support workers a priority when delivering urgent support to low income workers hit by sharply rising petrol prices.
Nicola Willis told media today she wants a ‘very targeted and temporary’ fix for those ‘acutely impacted’, adding she doesn’t want to see a situation where ‘people can’t drive to work.’
“We agree with Nicola Willis – and home support workers should be at the front of the queue – and right now there’s a fast, ready fix available that could be done today by raising their mileage allowance,” said Fleur Fitzsimons, National Secretary for the Public Service Association Te Pūkenga Here Tikanga Mahi.
The Finance Minister is seeking advice from Inland Revenue and Treasury about using the tax and transfer system to deliver support – tax credits under Working for Families or the Independent Earner Tax Credit. But neither may help many home support workers.
“These workers drive their own cars between clients every day, and are the only publicly funded workers required to do so with such a miserable mileage reimbursement. They have no choice but to drive and rising petrol prices are hitting them directly in the pocket with every shift.
“But there’s a simple, fast fix right now for these essential workers. The Home and Community Support (Payment for Travel Between Clients) Settlement Act 2016 requires Health NZ Te Whatu Ora to pay a mileage rate to these workers. The Health Minister can direct that rate to be lifted immediately, no complicated fiddling with the tax and transfer system required, no delay, just fast, real help.”
The allowance was last adjusted four years ago so should be being reviewed right now.
Fleur Fitzsimons said: “These are low-paid, predominantly female workers providing critical care to elderly and disabled New Zealanders. If the Government is serious about protecting working people from the fuel crisis, it can today deliver the support they need right now.
“The PSA urges the Government to do the right thing by these workers, today. They can’t afford to wait.”
Previous statement
The Public Service Association Te Pūkenga Here Tikanga Mahi is Aotearoa New Zealand’s largest trade union, representing and supporting more than 95,000 workers across central government, state-owned enterprises, local councils, health boards and community groups.

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/20/statement-home-support-workers-must-be-front-of-queue-for-fuel-fix-nicola-willis-psa/

Posted on

Li Ning Company Limited Announces 2025 Annual Results

Source: Media Outreach

Anchored in a “Single Brand, Multi-categories, Diversified Channels” Strategy
Technology and Premium Sports Resources Drive Our Competitive Edge

FINANCIAL HIGHLIGHTS

  • During the year, the Group recorded the following operating results:
    • Revenue rose by 3.2% to RMB29,598 million; gross profit margin declined by 0.4 percentage points to 49%
    • Net operating cash inflow was RMB4,852 million
    • Net profit attributable to equity holders was RMB2,936 million with net profit margin of 9.9%, and EBITDA margin was 20.8%
  • Working capital remained at a healthy level:
    • The percentage of gross average working capital to revenue was 7.7%
    • The cash conversion cycle was at 37 days, two days longer than last year
  • The Board has recommended the payment of final dividend of RMB23.36 cents per ordinary share for the year ended 31 December 2025, together with the interim dividend of RMB33.59 cents per ordinary share paid in September 2025, the total dividend for the year ended 31 December 2025 will amount to RMB56.95 cents per ordinary share or a total dividend payout ratio of 50%.

OPERATIONAL HIGHLIGHTS

  • The retail sell-through for the overall platform remained flat, including online and offline channels.
  • Offline new product sell-through accounted for 83% of overall offline sell-through, maintaining at healthy and reasonable level.
  • The overall channel inventory turnover was at 4 months, channel inventory level and ageing structure remained healthy.

HONG KONG SAR – Media OutReach Newswire – 19 March 2026 – Li Ning Company Limited (the “Company” or “Li Ning Company”; together with the subsidiaries, the “Group”; stock codes: 2331 (HKD counter) and 82331 (RMB counter)) today announced its audited annual results for the year ended 31 December 2025 (the “Year”).

Financial Results

In 2025, the Group continued to enhance the technological features of its products, optimising channel efficiency, and strengthening the brand’s professional positioning, delivering stable operating performance. During the year, the Group’s revenue amounted to RMB29,598 million, representing an increase of 3.2% compared with 2024 (2024: RMB28,676 million). Gross profit amounted to RMB14,489 million, up 2.4% from 2024 (2024: RMB14,156 million). The overall gross profit margin decreased by 0.4 percentage points to 49.0% (2024: 49.4%).

During the year, the net profit attributable to equity holders was RMB2,936 million (2024: RMB3,013 million). The margin of net profit attributable to equity holders was 9.9% (2024: 10.5%). Return on equity attributable to equity holders was 10.9% (2024: 11.9%). Basic earnings per share was RMB113.91 cents (2024: RMB116.98 cents). The Board has recommended the payment of a final dividend of RMB23.36 cents per ordinary share for the year ended 31 December 2025. Together with the interim dividend of RMB33.59 cents per ordinary share paid in September 2025, the total dividend for the year ended 31 December 2025 will amount to RMB56.95 cents per ordinary share or a total dividend payout ratio of 50% (2024: 50%).

In cash flow management, the Group’s net cash generated from operating activities during the year amounted to RMB4,852 million (2024: RMB5,268 million). As at 31 December 2025, cash and cash equivalents (including cash at banks and on hand, and fixed-term deposits with an original maturity of no more than three months) amounted to RMB16,717 million, an increase of RMB9,218 million compared with 31 December 2024. Adding back the amount recorded as fixed-term deposits held at banks, cash balance at 31 December 2025 amounted to RMB19,973 million, representing a net increase of RMB1,833 million compared with 31 December 2024. During the year, revenue increased year-on-year, while cash-based expenses including marketing costs and tax payments rose, coupled with the settlement time lag of e-commerce platforms, leading to a year-on-year decrease in net cash generated from operating activities. Meanwhile, the maturity and redemption of time deposits led to a significant increase in net cash generated from investing activities. The Group will continue to place extra emphasis on cash flow management to ensure the stable development of the Company in the long term.

Operational Summary

In 2025, the Group remained anchored in its “Single Brand, Multi-categories, Diversified Channels” strategy, advancing development through product upgrades, channel optimisation, and brand marketing.

The Group focused on six core categories—running, basketball, training, badminton, table tennis and sports casual—while actively pursuing opportunities in emerging fields and exploring new sports subcategories, such as outdoor, tennis and pickleball. During the year, the Group continued to upgrade its products through technological innovation and enhance the deployment of professional sports resources, guided by three key pillars: reinforcing a professional sports mindset, showcasing sports-fashion aesthetics, and honouring Chinese cultural heritage. In addition, it worked proactively to strengthen brand influence and increase brand recognition and visibility through diversified, and comprehensive marketing campaigns.

As the official partner of the Chinese Olympic Committee, the Group leveraged its deep expertise and strong professional sports credibility to blend sportsmanship with cutting-edge technology and Eastern aesthetics—all under the narrative theme “China’s Glory, Together with LI-NING.” During the year, it opened the world’s first LI-NING “Loong Store” and launched the “Glory Gold Label” product series, transforming exclusive, top-tier scarce sports resources into a driving force for brand reputation and market recognition, continuously strengthening consumers’ perception of LI-NING’s professional capabilities and product reliability.

In terms of channel development, the Group continued to advance a multi-dimensional channel network layout to expand market coverage while enhancing operational efficiency. In high-end markets, the Group deepened synergistic collaborations with top-tier commercial complexes and leading outlet malls, jointly promoting the planning and implementation of innovative stores. During the year, the Group successfully launched an independent outdoor store “COUNTERFLOW”, marking an important milestone for the brand’s official entry into the outdoor segment. The Group actively carried out cross-industry collaborations, partnering with top IPs embodying Chinese cultural heritage such as the Palace Museum, and launched marketing campaigns by collaborating with channel partners through diverse initiatives, effectively improving brand reach and conversion. In terms of efficiency enhancement, the Group continued to optimize the channel structure and improved rental structures and cooperation models, enhancing overall channel health and operational sustainability through a series of strategic optimization measures. As of 31 December 2025, the LI-NING brand (including LI-NING Core Brand and LI-NING YOUNG) operated a total of 7,609 conventional stores, flagship stores, China LI-NING stores, factory outlets, and multi-brand stores, representing a net increase of 24 POS compared with 31 December 2024.

In terms of retail operations, the Group built a highly profitable, efficient, and replicable single-store operating model. In high-level markets, targeted brand strategies were implemented across key regions, strengthening brand image and improving product operation efficiency through optimised channel structure, store product mix, and shopping experience. The Group established a distribution management model to improve operational efficiency and sustainable development capabilities of the distribution system. In addition, the Group strengthened the efficient coordination between retail outlets and the logistics system. Through refined planning systems, flexible supply chain construction and digital support, channel inventory turnover and full lifecycle product management were realised, thereby comprehensively improving operational quality and efficiency.

In terms of e-commerce operations, the Group made precise deployments that effectively enhanced consumer awareness and market share during major e-commerce campaigns such as Tmall Celebration Day and Tmall Super Product Day. During the year, core IP products such as “Zhui Feng”, “DLO”, “ULTRALIGHT” and “LI REN” delivered outstanding performance, successfully penetrating multiple consumer segments including Gen Z, professional sports and trendy fashion, ranking highly in both sales and reputation across segmented markets. By leveraging top athletes, celebrities, trending events and channel resources, the Group not only enhanced product exposure and achieved traffic acquisition and promotional sales conversion, helping inventory optimisation, but also supported offline business and drove overall revenue growth.

In terms of supply chain, the Group continuously optimised the supplier matrix, aligning high-quality supplier resources for high-end sports, outdoor, premium and sponsored product lines. Meanwhile, the Group aligned with its major product plan by adopting segmented production planning and data-driven management to achieve high-level coordination among product planning, supply chain, logistics, and retail outlets. To improve operational efficiency, the Group adopted multiple measures such as integration of fabric resources, optimization of process structures, large-scale procurement of materials and staggered production scheduling, further improving the cost structure, while enhancing production efficiency. In addition, the Group continued to integrate sustainable development into supply chain management and promoted green products, with the proportion of eco-friendly products exceeding annual targets during the year.

In terms of logistics, the Group launched a channel logistics project to connect the order system with logistics operations, improving product circulation efficiency and fulfilment timeliness. On the digital front, the Group introduced a warehouse coordination system and adopted SKU-level refined management. In terms of automation, automated equipment was introduced into various warehouses, enabling multi-scenario coverage and data visualization management. In December 2025, the East China and North China warehouses took the lead in adopting RFID full-process warehouse management, achieving full-process traceability of logistics data, greatly strengthening inventory management precision, and deployment across all warehouses is expected to be completed in the first quarter of 2026 to continuously drive cost reduction and efficiency improvement.

In terms of its kidswear business, LI-NING YOUNG continued to focus on professional sports and children’s developmental needs, advancing product optimization and exclusive IP creation. In terms of channel strategy, the Group continued to strengthen outlet channel development, improve single-store efficiency and optimize overall channel structure while accelerating its e-commerce deployment. LI-NING YOUNG maintained a coordinated development of wholesale and direct retail. Through refined management and strategic layout, both scale and quality were improved. In terms of marketing, LI-NING YOUNG centred its efforts around three core pillars “Event Cooperation + User Stories + IP Collaboration” to build professional recognition and accumulate its user foundation, successfully expanding its influence among youth and family demographics. As at 31 December 2025, the total number of LI-NING YOUNG POS was 1,518, representing a net increase of 50 POS since 31 December 2024.

Outlook

Entering 2026, the Group will seize the development opportunities arising from the continuous release of domestic demand potential. The Group will remain committed to its core value of “serving the public with sportsmanship,” meticulously refine its “LI-NING’s experience value,” and strive to become the preferred professional sports brand.

1. Technology-driven product upgrades: The Group will firmly implement the development strategy of “Single Brand, Multi-categories, Diversified Channels”, empowering product iterative upgrades with technology to build core competitiveness and market differentiation barriers. Relying on the technical accumulation and R&D of the LI-NING technology innovation platform, the Group will focus on deep cultivation of core categories and actively expand into emerging segments such as outdoor sports. The Group aims to respond to increasingly diversified and personalised consumer demands, achieving full-scenario coverage from professional competitive sports to daily wear. By promoting the ingenious integration of cutting-edge technology and fashion design, the Group will create a product system that combines excellent functionality, technological texture, and aesthetic value. Furthermore, the Group will continuously strengthen the efficiency of transforming scientific and technological achievements, promoting the rapid realization of frontier technologies into product competitiveness.

2. Olympic marketing empowering the brand: The Group will drive value creation through sports marketing, establish emotional connections with consumers, and facilitate the steady enhancement of brand value. By continuously deepening the cooperation with the Chinese Olympic Committee, the Group will seize the development window of the Olympic cycle and promote the brand to achieve a leap from resource cooperation to value co-creation. LI-NING will fully explore the diversified value of the cooperation with the Chinese Olympic Committee. Through systematic marketing layout and technological equipment support, it will convey the story of the mutual growth of LI-NING and Chinese sports, highlighting the technological strength and cultural confidence of the national brand.

3. Dual improvement in quality and efficiency of business operations: The Group will continue to focus on improving quality and efficiency across all aspects of its business. By deepening channel layout, strengthening product operations, and optimising supply chain management, the Group aims to build an efficient operational system, achieve simultaneous improvements in operational quality and efficiency, and lay a solid foundation for the high-quality growth of the enterprise. Offline channels will focus on improving efficiency in high-tier markets and penetrating emerging markets, while exploring new business models. Online channels will strengthen domain synergy and resource integration, promoting complementarity between online and offline channels. In terms of product operations, the Group will optimize the precision of full-chain planning and flexible supply capabilities, and accelerate inventory turnover. The supply chain will achieve coordinated optimization of cost, quality, and delivery time across the entire chain, thereby enhancing overall operational efficiency.

4. Consolidating the foundation to safeguard development: The Group will continuously strengthen three core support capabilities: talent, finance, and digital intelligence, to lay a solid bedrock for high-quality development. In terms of talent strategy, talent development will focus on selection, incentives, and efficiency. In terms of financial management, emphasis will be placed on precise resource allocation and risk control. In terms of digitalization, the Group will promote the deep integration of AI and big data with business operations, enhance operational efficiency and the scientific nature of decision-making, and provide systematic safeguards for the long-term development of the Group.

Mr. Li Ning, Executive Chairman and Joint CEO of the Group, concluded: “2026 marks the first year of the 15th Five-Year Plan. With the strategic goal of accelerating the development of a sports powerhouse, the nation will further unlock sports consumption potential while driving the transformation and upgrading of the sporting goods manufacturing industry. We expect this to release domestic demand potential and create both strong support and a vast stage for the sports industry to thrive.”

“We will remain rooted in the local market while looking ahead, seizing opportunities of the era with greater foresight and more efficient execution. We will continue to deepen the Group’s ‘Single Brand, Multi-categories, Diversified Channels’ strategy, optimising and upgrading our core category matrix while exploring emerging segments. Most importantly, we will keep strengthening the core advantages of our products—professional performance, technological capability, and sports experience—by empowering them with innovative technology and design aesthetics to reward consumer trust.”

Hashtag: #LiNing

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/20/li-ning-company-limited-announces-2025-annual-results/

Posted on

Art Central, In Collaboration With The Hong Kong Tourism Board, Presents The Hong Kong Art Month Discovery Guide And Introduces Travel And Experience Packages

Source: Media Outreach

Inviting visitors to Hong Kong Art Month for a cultural journey connecting art and the city

HONG KONG SAR – Media OutReach Newswire – 18 March 2026 – Art Central, in collaboration with the Hong Kong Tourism Board, is launching a digital Hong Kong Art Month Discovery Guide alongside a series of travel and experience packages for the Fair’s eleventh edition. These offerings bring visitors from the Greater Bay Area and overseas a seamless art travel experience, allowing them to enjoy Hong Kong’s diverse hotels, dining, attractions, and transport networks alongside their visit to the Fair.

As a cornerstone event of Hong Kong Art Month, Art Central returns to the iconic Central Harbourfront from 25 to 29 March 2026. The Fair brings together contemporary art, curated programmes, and a vibrant community of galleries, artists, collectors, overseas visitors, and local audiences to build a dynamic platform for artistic exchange. Art Central 2026 is financially supported by the Mega Arts and Cultural Events Fund under the Culture, Sports and Tourism Bureau of the Hong Kong Special Administrative Region Government.

Entering its second decade, Art Central 2026 will assemble 117 galleries and 500 artists from Hong Kong, Asia, and around the world, further reinforcing its position as an integral platform for discovery and exchange among collectors and curators. Co-curated by Enoch Cheng and Zoie Yung, the Fair’s eleventh edition will present a series of artistic programmes—including performances, video art, large-scale installations, and talks—examining the frictions and intimacies that shape contemporary social and virtual life, foregrounding emergent Asian voices.

To enrich the artistic journey for visitors, Art Central, in partnership with the Hong Kong Tourism Board, proudly presents the digital Hong Kong Art Month Discovery Guide. The guide compiles exciting events across the city’s art districts, covering gallery exhibitions, special museum showcases, and performing arts programmes across Central, Sheung Wan, Wan Chai, Tai Hang, the Southern District, Tsim Sha Tsui, and the West Kowloon Cultural District. Beyond visual arts, the guide offers detailed dining recommendations in the vicinity, perfectly illustrating Hong Kong’s diverse culinary culture. The curated selections range from local street food and refined Cantonese cuisine to Michelin-starred contemporary European dining. Featured establishments include MIAN, Amber, Belon, L’Atelier de Joël Robuchon, Chinesology, Gu Liang Cai, and the historic Luk Yu Tea House. Through this comprehensive guide, visitors can easily navigate the city’s streets and alleys alongside their visit to Art Central, seamlessly transitioning from visual arts to culinary delights while deeply experiencing Hong Kong’s unique charm as Asia’s events capital. Explore more in the Hong Kong Art Month Discovery Guide.

To allow visitors to incorporate the Fair into their broader Hong Kong itineraries with ease, Art Central has introduced a brand-new Flexible Date Ticket, available in limited quantities exclusively during the advance sale period. Holders of the Flexible Date Ticket may select any single day between 25 and 29 March 2026 for entry during general admission hours without the need for advance date selection.

Art Central has also launched comprehensive packages on various travel platforms covering accommodation, attractions, and transportation for the convenience of visitors. For example, through Ctrip, visitors can book curated packages combining Fair admission with selected offers and enjoy a HK$50 no-minimum-spend Uber Taxi promo code with the purchase of any ticket, easily charting a cultural journey connecting art and city life.

Ctrip’s accommodation bundles span top-tier five-star luxury properties such as Four Seasons Hotel Hong Kong, Mandarin Oriental Hong Kong, and The Murray, Hong Kong, as well as boutique options including The Pottinger Hong Kong, offering convenient and elevated choices for cultural getaways and weekend itineraries.

Additionally, attraction bundles will extend the Fair experience to multiple transportation options and popular leisure destinations, including the Peak Tram, the Hong Kong Observation Wheel, the Star Ferry, and the Airport Express. This allows visitors to integrate transportation, accommodation, and urban cultural experiences, extending their exhibition visit into a city journey exploring Hong Kong’s art and lifestyle.

Furthermore, Art Central has launched combo packages on Klook, pairing the Flexible Date Ticket with admission to the Hong Kong Observation Wheel at the Central Harbourfront (HK$302) or a Cupping Room coffee e-voucher (HK$314). These allow visitors to take in the spectacular views of Victoria Harbour or take a relaxing coffee break following their visit to the Fair. After viewing the exhibition, visitors can also take the “WestK Ferry” from Central Pier 9—a short eight-minute ferry ride—to effortlessly reach the West Kowloon Cultural District and continue their exploration at M+, the Hong Kong Palace Museum, and the WestK FunFest.

Package offers are exclusively available for purchase via Ctrip and Klook. For more details regarding participating hotels, dining, attractions, and transport partners, please visit artcentralhongkong.com/tickets. Ticket Packages might be subject to change without prior notice and are available in limited quantities while stocks last.

​
Art Central 2026 Package Offers

Category Package Price Booking Channel Remarks
Fair Ticket Art Central Advance Ticket +

Uber Taxi HK$50 Promo Code

 Adult: HK$180
Child: HK$55		 Ctrip
Experience Art Central Advance Ticket

+ Peak Tram Return Ticket + Sky Terrace 428 + Uber Taxi HK$50 Promo Code

 Adult: HK$305
Child: HK$305		 Ctrip
Experience Art Central Advance Ticket +

Hong Kong Observation Wheel Ticket + Uber Taxi HK$50 Promo Code

 Adult: HK$164
Child: HK$54		 Ctrip
Experience Art Central Advance Ticket + Star Ferry World Star / Shining Star Water Tour Ticket + Uber Taxi HK$50 Promo Code Adult: HK$351
Child: HK$188		 Ctrip
Transport Art Central Advance Ticket +

Airport Express Ticket to/from Central (Hong Kong Station) + Uber Taxi HK$50 Promo Code

 Child: HK$89 Ctrip
F&B Art Central Advance Flexible Date Ticket +

Cupping Room HK$50 Coffee E-Voucher

 HK$314 Klook
Experience Art Central Advance Flexible Date Ticket +

Hong Kong Observation Wheel Ticket

 HK$302 Klook
Hotel Art Central Advance Ticket + Hotel Bundle RMB ¥581+ Ctrip Options include:
Four Seasons Hotel Hong Kong / The Upper House / Mandarin Oriental Hong Kong / Island Shangri-La, Hong Kong / The Murray, Hong Kong, a Niccolo Hotel / JW Marriott Hotel Hong Kong / The Pottinger Hong Kong / Two MacDonnell Road, Hong Kong / Lan Kwai Fong Hotel @ Kau U Fong / Bishop Lei International House

Opening Dates and Hours
Tuesday 24 March
VIP Preview (by invitation)

Wednesday 25 March
Fair Hours 12 pm – 5 pm
Night Central 5 pm – 9 pm

Thursday 26 March
Fair Hours 12 pm – 7 pm

Friday 27 March
Fair Hours 12pm – 7 pm

Saturday 28 March
Fair Hours 11 am – 7 pm

Sunday 29 March
Fair Hours 11 am – 5 pm

Venue
Central Harbourfront Hong Kong, 9 Lung Wo Road

https://artcentralhongkong.com/
https://www.facebook.com/artcentralhk
Wechat: https://artcentralhongkong.com/wechat/
https://www.instagram.com/artcentralhk/

Hashtag: #ArtCentralHK #ArtCentralUOB #HongKongArtWeek

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/19/art-central-in-collaboration-with-the-hong-kong-tourism-board-presents-the-hong-kong-art-month-discovery-guide-and-introduces-travel-and-experience-packages/

Posted on

GMG Productions, David Ian For Crossroads Live and Work Light Productions Presents The Regent’s Park Open Air Theatre Production of Jesus Christ Superstar

Source: Media Outreach

THE AWARD-WINNING PRODUCTIONOF THE GLOBAL PHENOMENON JESUS CHRIST SUPERSTAR WILL VISIT THE GRAND THEATRE, HONG KONG CULTURAL CENTRE FROM 8 JULY AS PART OF ITS INTERNATIONAL TOUR

TIM RICE AND ANDREW LLOYD WEBBER’S ICONIC ROCK MUSICAL COMES TO HONG KONG FOR THE VERY FIRST TIME

PRIORITY BOOKING FROM25 -26 MARCH | PUBLIC SALE ON 27 MARCH

HONG KONG SAR – Media OutReach Newswire – 17 March 2026 – Following several acclaimed and sold-out runs in London as well as an extensive tour of North America, UK and Australia, the Olivier Award-winning reimagined production of Tim Rice and Andrew Lloyd Webber’s celebrated musical JESUS CHRIST SUPERSTAR will visit the Grand Theatre, Hong Kong Cultural Centre from 8 July as part of a major international tour, giving Hong Kong audiences their first opportunity to experience Tim Rice and Andrew Lloyd Webber’s legendary rock musical live on stage.

“A gorgeous, thrilling, heavenly musical.”

– The Guardian

“Hallelujah! An almighty revelation.”

– The Daily Telegraph

Featuring lyrics and music by Emmy, GRAMMY, Oscar and Tony winners Tim Rice and Andrew Lloyd Webber, this production was reimagined by London’s Regent’s Park Open Air Theatre where it originated and is helmed by director Timothy Sheader and choreographer Drew McOnie. Completing the creative team is design by Tom Scutt, lighting design by Lee Curran, sound design by Nick Lidster and music supervision by Tom Deering.

A global phenomenon that has wowed audiences for decades, JESUS CHRIST SUPERSTAR is a timeless work that explores the biblical portrayal of the extraordinary events that led to the death and resurrection of Jesus Christ as seen through the eyes of his betrayer, Judas Iscariot. The story, told entirely through song, explores the personal relationships and struggles among Jesus, Judas, Mary Magdalene, Jesus’ disciples, his followers and the Roman Empire. Originally released as a concept album, the iconic 1970s rock score contains such well-known numbers as ‘Superstar’, ‘I Don’t Know How to Love Him’, and ‘Gethsemane’.

JESUS CHRIST SUPERSTAR opened on Broadway in 1971 at the Mark Hellinger Theatre. The original London production opened at the Palace Theatre on 9 August 1972 and ran for over eight years. By the time it closed, after 3,358 performances, it had become the longest-running musical in West End history at that time. JESUS CHRIST SUPERSTAR has been reproduced regularly around the world in the years since its first appearance, with performances including a Broadway revival in 2012, an ITV competition TV show called Superstar that led to casting Ben Forster as Jesus in an arena tour of the show, and a production at the Regent’s Park Open Air Theatre celebrating 45 years since the musical’s Broadway debut. JESUS CHRIST SUPERSTAR will also have a limited run at the iconic London Palladium in summer 2026, starring Sam Ryder as Jesus. Produced by Michael Harrison for Lloyd Webber Harrison Musicals, this production was originally created and produced at Regent’s Park Open Air Theatre.

Producer David Ian said: “This Olivier Award-winning production of JESUS CHRIST SUPERSTAR has amazed audiences around the world, and we are thrilled to bring this phenomenon to the stage in Hong Kong. Marking the first Hong Kong season of Tim Rice and Andrew Lloyd Webber’s iconic rock musical, this engagement promises a spectacular new chapter for local audiences.”

GMG Productions CEO Carlos Candal shares“GMG Productions is thrilled to be bringing this extraordinary show to Hong Kong. Building on our growing success across Asia, we are proud to present such a dynamic and high-calibre production as part of our long-term commitment to delivering world-class entertainment in the region.”

This production of JESUS CHRIST SUPERSTAR won the 2017 Olivier Award for Best Musical Revival and the 2016 Evening Standard Award for Best Musical, selling out two consecutive engagements in 2016 and 2017. The production played a West End engagement at the Barbican in 2019 before returning to Regent’s Park Open Air Theatre in concert version during the summer of 2020, followed by a universally acclaimed UK tour in 2023/24.

Casting to be announced.

The 2026 Tour of JESUS CHRIST SUPERSTAR is produced by David Ian for Crossroads Live and Work Light Productions. The original production was produced by London’s Regent’s Park Open Air Theatre.

JESUS CHRIST SUPERSTAR will be performed in English with Chinese surtitles.

Tickets for the Hong Kong season will go on sale soon. Sign up to our online Priority List now at https://jesuschristsuperstar.hk to enjoy a 10% discount during Priority Booking from 25 March, 10am, for 48 hours. General Public Ticket Sales launch on 27 March; tickets are priced from HK$588 to $1,088.

For additional information about this production, please visit https://jesuschristsuperstar.hk

Facebook & Instagram: @GMGProductionsHK

SHOW AND TICKETING INFORMATION

DATES:
8 July – 1 August 2026

PERFORMANCE TIMES:
Tuesdays- Fridays: 8pm
Saturdays: 3pm and 8pm
Sundays: 2pm and 7pm

VENUE:
Grand Theatre, Hong Kong Cultural Centre, 10 Salisbury Rd, Tsim Sha Tsui

PERFORMANCE DURATION: 1 hour 50 mins including interval

TICKET PRICES:

VIP HK$1,088
A Reserve HK$988
B Reserve HK$888
C Reserve HK$688
D Reserve HK$588
Concession VIP HK$988
Concession A HK$888
Concession B HK$788

Concession tickets are available to full-time students, senior citizens aged 60 or above, persons with disabilities and CSSA recipients.

Performed in English, with Chinese surtitles

BOOKINGS
Website: https://jesuschristsuperstar.hk
Priority Booking from 25 March, 10am, for 48 hours; General Public Sales from 27 March.

Hashtag: #JesusChristSuperstar

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/17/gmg-productions-david-ian-for-crossroads-live-and-work-light-productions-presents-the-regents-park-open-air-theatre-production-of-jesus-christ-superstar/

Posted on

PSA – Help us now – 23,000 home support workers hit by petrol price hikes urge Govt. to act

Source: PSA

The PSA is urging Finance Minister Nicola Willis to walk the talk and deliver support for a key group of hard working New Zealanders struggling with rising fuel costs from the Iran war – 23,000 home support workers.
The Finance Minister today said the Government was considering targeted, timely and temporary options for low income New Zealanders facing increased fuel costs triggered by the Iran war.
“There are 23,000 home support workers on low wages who look after our most vulnerable people – the elderly, disabled and injured – every single day who need help urgently, right now. They deserve better than being left to foot the bill,” said Fleur Fitzsimons, National Secretary for the Public Service Association Te Pūkenga Here Tikanga Mahi.
Workers like Pam McLaren from Blenheim are feeling the squeeze on her budget as petrol prices rise. “I’ve done the calculations, it’s going to cost me $75.66 more per week to run my vehicle. I don’t know where that money’s meant to come from. It’s ending up costing a lot to go to work, and it’s not like I can ride a bike between clients, the distance is too far.”
Fleur Fitzsimons: “If the Government is serious about relieving cost of living pressures in a targeted way, then it must follow through on today’s promise and make it a priority to compensate them for rising fuel bills. It’s the right thing to do.”
Home support workers drive their own cars between clients, caring for the elderly, disabled and injured every day, but are being reimbursed at just 63.5 cents per kilometre, well below the IRD rate, and less than half of the travel costs they face.
“These workers were already being undercompensated before the fuel crisis. They are also disadvantaged by the Government’s scrapping of a pay equity pay rise last year. They cannot afford to subsidise the cost of delivering essential government-funded services.”
Travel costs for home support workers are governed by the In Between Travel Settlement Act, introduced under a National-led Government in 2015. There have been only two increases to the mileage rate in a decade, the last one was four years ago.
“It’s well past time for an urgent review,” said Fleur Fitzsimons.
“Funding for home support already flows through MSD and the Ministry of Health. An increase to the mileage rate can be delivered quickly and efficiently through existing channels. There is no excuse for delay.”
The PSA will be raising this issue urgently with the Government.
The Public Service Association Te Pūkenga Here Tikanga Mahi is Aotearoa New Zealand’s largest trade union, representing and supporting more than 95,000 workers across central government, state-owned enterprises, local councils, health boards and community groups.

MIL OSI

LiveNews: https://livenews.co.nz/2026/03/16/psa-help-us-now-23000-home-support-workers-hit-by-petrol-price-hikes-urge-govt-to-act/

Posted on

NZ-AU: The Middle East: Impact of the U.S.–Israel War on Iran and Challenges for U.S. Expats

Source: GlobeNewswire (MIL-NZ-AU)

Dubai, UAE, March 13, 2026 (GLOBE NEWSWIRE) — Expat US Tax has released an analysis examining how recent geopolitical developments in the Middle East are affecting Americans living and traveling across the region. The review focuses on practical issues that U.S. expats may encounter, including travel disruptions, embassy advisories, and day-to-day logistical challenges as governments monitor security developments.

Impact of the U.S.–Israel War on Iran and Challenges for U.S. Expats

Over the past several weeks, tensions involving the United States, Israel, and Iran have led to heightened security alerts and precautionary measures across parts of the Middle East. Governments in several countries have issued travel advisories, increased security measures around infrastructure and transportation networks, and temporarily adjusted airspace access in response to regional developments.

These changes have had a direct impact on international travel. Airlines operating across the Middle East have modified flight routes or temporarily suspended certain services when airspace restrictions were introduced. In some cases, travelers have experienced delays or cancellations as airlines adjusted operations to maintain safe flight paths.

For Americans living in the region, these developments can affect routine activities such as business travel, family visits, or relocation plans. Large American expatriate communities reside in countries including the United Arab Emirates, Saudi Arabia, Qatar, Israel, and Kuwait, where many work in sectors such as energy, aviation, finance, education, and international business.

Clark Stott, Director at Expat US Tax, said that events affecting regional transportation or embassy operations can have practical implications for Americans living abroad.

“Americans living overseas often manage international travel, cross-border employment, and family commitments in multiple countries,” Stott said. “When regional developments affect transportation or consular services, expatriates may need to adjust travel plans or monitor official government guidance more closely.”

Government agencies have encouraged citizens abroad to stay informed through official advisories and embassy updates. U.S. citizens living overseas may receive updates through embassy communications, travel advisories, and emergency notification systems designed to provide timely information during rapidly evolving situations.

Travel and Embassy Operations

One of the most immediate effects of regional instability is the adjustment of aviation routes and airport operations. Airlines may reroute flights to avoid restricted airspace, while airports can temporarily limit operations if security concerns arise. These changes may result in longer travel times or limited flight availability between international hubs.

Embassy services may also adjust operations during periods of heightened security awareness. While most diplomatic missions continue to provide routine consular services, embassies may issue additional guidance for citizens or temporarily modify staffing levels depending on local conditions.

For Americans abroad, embassy communication channels often serve as an important source of information. Citizens can receive updates regarding local developments, travel advisories, or recommended safety precautions.

Considerations for U.S. Expats

For expatriates living in the Middle East, the most common impacts tend to involve logistical and planning considerations rather than direct security concerns. Travel arrangements, visa timelines, and relocation plans can be affected when airlines modify schedules or when governments introduce temporary travel guidance.

Many expatriates also maintain connections across multiple countries, making regional mobility an important part of daily life. Business travelers, contractors, educators, and international employees may rely on regional flights between Gulf cities, Europe, and Asia. Changes in aviation routes or airport operations can therefore influence professional schedules and personal travel.

In these situations, experts generally recommend monitoring official government advisories and maintaining flexibility in travel planning. Staying informed through embassy updates and airline notifications can help expatriates respond to changing travel conditions.

U.S. Tax Considerations for Americans Abroad

In addition to travel logistics, Americans living overseas continue to manage ongoing financial and tax obligations in the United States. Unlike most countries, the United States taxes its citizens based on citizenship rather than residency. As a result, U.S. citizens living abroad generally remain required to file annual U.S. tax returns if their income exceeds certain thresholds.

For expatriates who move between countries or adjust employment arrangements due to regional developments, maintaining accurate financial records can be especially important. Changes in residency, employment contracts, or income sources may affect how certain tax provisions apply.

Clark Stott noted that geopolitical developments sometimes highlight the complexity of financial planning for Americans abroad.

“Even during periods of regional uncertainty, U.S. tax filing requirements continue to apply,” Stott said. “For expatriates who relocate, change employment, or move between countries, maintaining organized financial records and understanding filing obligations can help avoid compliance issues later.”

U.S. expats may also rely on provisions such as the Foreign Earned Income Exclusion and foreign tax credits, which are designed to help reduce double taxation for Americans working overseas.

Looking Ahead

While governments and international organizations continue to monitor developments across the Middle East, many analysts note that travel conditions and security advisories can evolve quickly during periods of geopolitical tension.

For Americans living abroad, access to accurate information and reliable guidance remains important. Monitoring embassy communications, staying informed about travel advisories, and maintaining awareness of administrative obligations can help expatriates navigate changing conditions while continuing their work and daily life overseas.

About Expat US Tax

Expat US Tax is an advisory firm that assists U.S. citizens living abroad with tax compliance, planning, and reporting obligations. The firm provides tax preparation and advisory services to Americans residing in more than 190 countries, helping expatriates navigate the complexities of U.S. citizenship-based taxation.

Press Inquiries

Clark Stott
info@expatustax.com
https://www.expatustax.com/

– Published by The MIL Network

LiveNews: https://livenews.co.nz/2026/03/14/nz-au-the-middle-east-impact-of-the-u-s-israel-war-on-iran-and-challenges-for-u-s-expats/

Posted on

Sunlight Real Estate Investment Trust (“Sunlight REIT”) Final Results for the Year Ended 31 December 2025

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 11 March 2026 – Henderson Sunlight Asset Management Limited (the “Manager“) announces the final results of Sunlight REIT for the year ended 31 December 2025 (the “Year“).

Sunlight REIT recorded total revenue and net property income for the Year of HK$778.1 million and HK$601.0 million respectively, down 4.8% and 5.3% as compared to their corresponding calendarized figures in 2024. Distributable income for the Year exhibited a milder drop of 2.1% to HK$330.2 million, mainly attributable to a 16.1% saving in interest expense.

The key performance indicators on a calendarized basis are summarized as follows:

in HK$’ million 12 months ended

31 December 2025

 12 months ended

31 December 2024*
Revenue 778.1 817.1
Net property income 601.0 634.5
Distributable income 330.2 337.3

* unaudited figures derived from the audited financial statements for the 18 months ended 31 December 2024.

The Board has resolved to declare a final distribution of HK 9.1 cents per unit, bringing distribution per unit for the Year to HK 18.2 cents, which represents a payout ratio of 96.1% and a yield of 7.7% based on the closing unit price of HK$2.35 on the last trading day of the Year.

The appraised value of Sunlight REIT’s portfolio was HK$17,403.0 million at 31 December 2025, while its net asset value stood at HK$12,402.6 million, or HK$7.09 per unit.

Operating Highlights

At 31 December 2025, the occupancy rate of Sunlight REIT’s overall portfolio was 90.6%. The corresponding figures of the office and retail portfolios were 91.2% and 89.6%, with average passing rents of HK$31.0 per sq. ft. and HK$63.9 per sq. ft. respectively.

In respect of capital management, Sunlight REIT successfully completed the refinancing of borrowings in the amount of HK$2,980 million on favourable interest margin during the Year, demonstrating the staunch support from key bankers and the solid fundamentals of Sunlight REIT. All term loans of Sunlight REIT are currently being structured as sustainability-linked loans.

During the year under review, Sunlight REIT attained the five-star Global Real Estate Sustainability Benchmark (GRESB) rating, a testament to its commitment to sustainability.

Mr. Au Siu Kee, Alexander, Chairman of the Manager, said, “Given the prevailing operating environment, it is imperative to stay vigilant and adaptable, focusing on strategic cost management and portfolio optimization while leveraging technology to navigate the evolving landscape. We take pride in having established a firm foundation for Sunlight REIT, being strengthened by numerous initiatives amidst the ebbs and flows of the market. Unitholders are assured of this defensive and proactive culture in the years to come.”

Remarks: Attached financial highlights of FY2025 final results of Sunlight REIT.

Financial Highlights of FY2025 Final Results
(in HK$’ million, unless otherwise specified)

Year ended

31 December 2025

 18 months ended

31 December 2024
Revenue 778.1 1,236.3
Net property income 601.0 957.7
Cost-to-income ratio (%) 22.8 22.5
Loss after taxation (275.4) (173.0)
Distributable income 330.2 499.7
Distribution per unit (HK cents) 18.2 27.4
Payout ratio (%) 96.1 94.0
At 31 December

2025

 At 31 December

2024
Portfolio valuation 17,403.0 17,933.6
Net asset value 12,402.6 13,010.1
Net asset value per unit (HK$) 7.09 7.53
Gearing ratio (%) 27.8 27.0

Disclaimer: The information contained in this press release does not constitute an offer or invitation to sell or the solicitation of an offer or invitation to purchase or subscribe for units in Sunlight REIT in Hong Kong or any other jurisdiction.

Hashtag: #SunlightREIT #REIT

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/12/sunlight-real-estate-investment-trust-sunlight-reit-final-results-for-the-year-ended-31-december-2025/

Posted on

Bora Delivers Highest Operating Cash Flow Margin Since 2020, Enabling 2026 Bolt-On Investments from a Larger, Stronger Platform

Source: Media Outreach

HONG KONG SAR – Media OutReach Newswire – 11 March 2026 – Bora Pharmaceuticals (“Bora”; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for full year 2025 and provides 2026 outlook.

FY25 Business and Financial Highlights

  • Company reported full year revenues, with discontinued operations reported separately, of NT$19,014 million, up 9.11% from the prior year and basic EPS of NT$23.90, or NT$2.63 for the fourth quarter. Full year EPS represents a 24.22% year-over-year decline, mostly due to a net loss per share of NT$11.24 from discontinued operations.
  • In the fourth quarter, following the completion of tech transfer of production transitions out of the Plymouth area in Minnesota, the COGS of those originally Plymouth-made inventories have been reconsolidated to COGS line. Hence on a like-for-like basis when compared with other quarters in 2025, fourth quarter gross margin would have been approximately 38-39%. The reported high single-digit percentage sequential decline in gross margin, which also led to softened operational leverage, was primarily attributable to a temporary slowdown in DLS orders from following the entry of a new competitor in Nov. with limited launch visibility during the quarter. Higher effective tax rates during the quarter were a direct result of less sell-through downstream from related party transactions of the internally manufactured generic products. In addition, heightened generics competition of Topiramate ER, a leading generics product of Upsher-Smith, was also a negative gross margin mover.
  • Management believes the 4Q25 OPEX profile more accurately reflects the expanded operating platform and our strategic repositioning into new focus areas. Sales and marketing expenses increased seasonally in line with market share cadence and channel expansion initiatives, while R&D spending sat on the disciplined side. Gross margin expansion serves as the key lever for operating leverage as scale improves fixed-cost absorption.
  • Pharma sales revenue remained volatile in the fourth quarter as legacy inventory phased out and new product approvals remain pending. Generics portfolio competitiveness remains a key focus area in the near term for both top line and gross margin. Nevertheless, led by vigabatrin franchise, Bora’s rare disease portfolio continued to gain impressive market share across dosage forms. The Company aims to actively refill pipelines in 2026 to regain profitable growth.
  • The Group’s CDMO business delivered another strong quarter in both revenues and gross margin. Supported by expanded capacity and the addition of new dosage forms, CDMO revenues grew 53.8% year-over-year in 2025 to NT$10.64 billion, including internal orders. Excluding internal orders, revenues reached NT$7.50 billion, representing a 19.53% increase compared to 2024.
  • As 2025 marked a year of post-merger integration and strategic consolidation, Bora achieved its highest operating cash flow margin in recent years at 34.74% in the fourth quarter, compared with -4.00% in the same period last year. This improvement reflects the transformation of the Bora Group into a more efficient organization operating on a larger and stronger platform. The Board has proposed a NT$10 cash dividend per share, demonstrating confidence in the Group’s strengthened cash generation and commitment to delivering sustainable returns to shareholders, reaching the highest yield rate proposed.
  • Share capital increased 3.18% during the quarter from employee stock option exercise and convertible bond conversions.

Mr. Bobby Sheng, Chairman of Bora Group, stated, “2025 represented a pivotal year for Bora Group. Beyond post-acquisition integration, it was a year of disciplined capital allocation and balance sheet stewardship. Having stepped onto a larger growth platform, we deliberately reassessed optimal cash deployment, portfolio mix of both CDMO and Pharma Sales businesses and forthcoming return metrics under a stable equity structure. One year after closing the 2024 acquisitions, we achieved our highest operating cash flow margin, marking a complete turnaround from the same period last year when the Group first transitioned to its current scale.

The external environment was marked by significant shifts. We operated against a backdrop of renewed U.S. trade and industrial policy shifts, triggering supply chain realignment and foreign exchange fluctuations. At the same time, rapid AI adoption began reshaping manufacturing competitive dynamics, if not capital market funding flow. Concurrently, the Group faced competition in a handful core generic products that remain meaningful contributors to revenue and EBITDA. Discontinued operations aside, based on the reclassified financial statements for 2025 and 2024, EBITDA for continued operations declined 19.0% compared to 2024, but remains 12.5% higher than 2023, underscoring the structurally higher revenues and earnings base established over the past 2 years.

Despite these headwinds, the Group remained profitable and has preserved financial flexibility. Notably, we funded Bora’s largest CDMO CAPEX program in our history and executed the business transformation of Upsher-Smith entirely within existing credit facilities, without incremental equity dilution. While value expansion of this new Bora Group platform took longer than the Company expected, we believe the year demonstrates the resilience of our operating model, disciplined financial management, and our ability to execute strategic investments while maintaining earnings and balance sheet integrity.

We are especially delighted to share the contract renewal with GSK earlier this year. From day one, this partnership was built on mutual trust and a shared commitment to quality. With the latest developments, we are looking at a decade of collaboration with GSK and committing through 2030 speaks to our shared focus on value and reliability. We have also established new partnerships with several high-growth pharmaceuticals over the past few months, further expanding our client base across our North American network. These partners share our belief in an integrated and orchestrated supply chain model, leveraging our multi-site platform to support development, manufacturing, and commercialization needs.

To sum up, the CDMO rolling 12-month external order backlog, after a good quarter of digestion and less working days, arrived at US$264 million. Total external wins in 2025 reached a phenomenal US$482 million, of which 89% were commercial-stage orders and 16 molecules in pre-commercial stage, providing solid visibility into 2026 and beyond especially for Canada and Baltimore sites. At the same time, Bora continues to leverage a unified CDMO network to enhance cost competitiveness for our very own Upsher-Smith generics portfolio.

On the pharma sales side, Upsher-Smith today represents a structurally repositioned platform. Performance has been increasingly driven by lifecycle management, including continued maximization of the infantile spasm franchise, alongside active pipeline replenishment with a heightened focus on differentiated assets, particularly NCEs in rare diseases. Within Generics, we have confirmed 7 launches in 2026, including the recently approved Cyclosporine and an in-licensed product indicated for hyponatremia. We are also observing a more constructive environment for DLS than initially anticipated, with 2026 year-to-date market share maintained. Last but not least, based on our current knowledge of the relevant U.S. patent rulings, if TWi receives approval for Cladribine (gMavenclad), Upsher-Smith, as the exclusive distributor, would be positioned to launch the product in the U.S., subject to customary regulatory and commercial considerations.

Beyond our base expectation of launching more than 10 generic products annually, we have identified revenue and EBITDA accretive, bolt-on investment opportunities to further strengthen this business in 2026. These include progressively expanding our injectable and 505(b)(2) portfolios to enhance differentiation and economics, as well as deepening penetration across proprietary and specialty distribution channels. When we exit this year with a more diversified and better-calibrated product mix, we expect improved earnings resilience and more stable growth trajectory going forward.”

FY25 Operational Achievements & 2026 Outlook

Global CDMO Operations

Global CDMO operations revenue reached record highs for both the quarter and the full year, accounting for approximately 45.78% of reported revenues in the quarter and 39.43% for FY2025. In total, 2.5 billion doses were developed and manufactured. Revenue contribution from the top 20 global pharmaceutical companies declined slightly to 29% from the low-30% range previously, primarily reflecting the addition of several fast-growing pharmaceutical clients to the Company’s portfolio in recent years, with increasing contributions from their successful product launches.

As the Company continues to expand its CDMO capacity and capabilities, including approximately 10% additional aseptic fill/finish capacity and a net ~3% expansion in solid and liquid dosage capacity, Bora Group monitors utilization rate carefully across facilities. While the Company remains confident that investing in U.S. manufacturing capacity is strategically sound, given the importance of the U.S. pharmaceutical market and supply chain resilience, capital allocation must also align with prevailing industry investment cycles. Against this backdrop, a structural supply gap in single-use drug substance (DS) bioreactor capacity, projected to grow at an estimated 8–10% CAGR, reinforces the rationale for continued investment in Tanvex Biopharma (branded as Bora Biologics) as Bora Group expands its CDMO platform. Supported by a more favorable funding environment for early-stage biotech companies in the US, rapidly growing biologics pipeline, increasing FDA approvals, long product lifecycles, and Tanvex’s integrated access to Bora’ Group’s drug product (DP) fill/finish capabilities, the strategic platform presents a compelling long-term value creation opportunity. While this represents a near-term drag on reported earnings, the Company believes these investments are necessary to position Bora Group for long-term participation in the CDMO market that values quality and OTIF (On Time, In Full) delivery.

Pharma Sales Operations

Pharma Sales operations generated revenue of NT$2.64 billion in the fourth quarter, marking one of slowest quarters since the Upsher-Smith merger. For the full year, Pharma Sales declined 11.30% compared to 2024, excluding the impact of discontinued operations related to delisted products, and accounted for 60.48% of total revenues.

A key leading indicator in specialty pharma is the number of new patients, and across the Vigabatrin franchise, Upsher-Smith continues to demonstrate positive momentum on this front. Upsher-Smith intends to pursue enhanced customer segmentation to further increase salesforce effectiveness in 2026 with investments in key commercial functions and patient access to increase salesforce effectiveness.

Recent Investor Conference

Bora will host an English online earnings call at 9:30 p.m. Taiwan time on Mar. 12th, 2026, followed by an investor conference hosted by Taishin Securities at the Regent Taipei at 2:00 p.m. on Mar. 19th, 2026. Both events will cover the Company’s 2025 financial and business results and 2026 outlook.

English Online Earnings Presentation Link: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5255333/bora-pharmaceuticals-otcqx-boray-twse-6472

Bora will participate in 2026 Jefferies Asia Forum in March in Hong Kong and an East coast NDR in NYC and Boston. For 1:1 meetings with management, please contact your Jefferies and Sinopac representative.

Bora 2026 Earnings Schedule

Q1 2026: Expected in the 2nd week of May 2026
Q2 2026: Expected in the 2nd week of Aug 2026
Q3 2026: Expected in the 2nd week of Nov 2026
Q4 2026: Expected in the 2nd week of Mar 2027

Hashtag: #Bora

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/11/bora-delivers-highest-operating-cash-flow-margin-since-2020-enabling-2026-bolt-on-investments-from-a-larger-stronger-platform/

Posted on

NZ-AU: SFIO closes $5-M series of global distribution partnerships for premium beverages and New Zealand Manuka honey

Source: GlobeNewswire (MIL-NZ-AU)

NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) — Global asset management company Starfleet Innotech, Inc. (OTC: SFIO-Smokefree Innotec, Inc.) entered into a partnership last month with food ingredients supplier Annapolis Co., Ltd., granting SFIO distribution rights over a suite of products under their premium beverage solutions brand LongBeach. This is the latest in a series of agreements the asset company has signed, following a similar arrangement with SFIO’s New Zealand-based subsidiary Gorgeous Coffee Co. Altogether, these partnerships are projected to launch SFIO towards their $100 million revenue target by the end of 2022.

With this latest partnership, Thailand’s leading premium ingredients supplier for beverages and bakeries, Annapolis Co., Ltd. will see its LongBeach brand premium purees, syrups, sauces, powders, and teas sold across SFIO’s sprawling food service network in Australia and New Zealand.

According to the latest data from Statista, despite the ongoing pandemic, Australia and New Zealand’s cafes, restaurants, and takeaway food services together present a roughly $36 billion market, which is expected to grow steadily over the next few years. Beginning January 2022, SFIO will be the sole distributor of LongBeach products across these two markets’ thriving food service industries. The company expects this deal alone to bring in up to $5 million in additional revenue for SFIO’s food and beverage division.

Earlier this year, SFIO established a global expansion roadmap for their fully-owned subsidiary Gorgeous Coffee Co. that would see New Zealand Manuka honey and a premium health brand of 5-in-1 Instant Coffee reaching US shelves as early as next year.

New Zealand’s Manuka honey, considered the best in the world, is a highly valued, energy-boosting superfood boasting a distinct earthy flavor and health benefits such as antioxidants, probiotics, and antibacterial support. The honey is graded according to a global potency scale called the Unique Manuka Factor, or UMF. Coming January 2022, SFIO will be distributing Manuka honey variants including UMF 5+, UMF 10+, UMF 15+, and UMF 20+.

Revenues from this arrangement are expected to reach $1 million by the end of 2022. Samples of the Manuka honey products have already been shipped to the United States and parts of the United Arab Emirates, with SFIO currently working on sending more to other countries across Asia.

Similarly, Gorgeous Coffee Co.’s 5-in-1 Instant Coffee will be exported across the United States, Australia, and Asia, including the United Arab Emirates. The product is a healthful mix of premium Arabica coffee, Manuka honey, barley grass, non-dairy MCT creamer, and Stevia. In addition to the benefits of Manuka honey, the instant coffee mix claims to aid in digestion, reduce inflammation, and boost immunity thanks to its barley components. Followers of the popular keto diet will also appreciate the instant coffee’s MCT creamer, an easy-to-digest alternative to traditional dairy.

The instant coffee product is expected to bring in at least $2 million in additional revenue for SFIO. Samples have already been sent to potential partners in the United States.

These partnerships play into the asset management company’s long-term ecosystem strategy, which prioritizes high-value synergies across its growing portfolio of companies. Leveraging the expanding footprint of its food and beverage businesses, including flagship franchise business Epiphany Cafe, these products will be rapidly stocking shelves across the globe as early as the first quarter of next year.

For media enquiries, please contact:
Craymond Yeong, PR & Marketing Specialist
Epiphany Café
Phone: (+64) 21 0833 2966
Email: info@sfio.co.nz

About Starfleet Innotech, Inc.
Starfleet Innotech, Inc. (OTC: SFIO-Smokefree Innotec, Inc.) is an asset management company focused on innovation through disruptive collaborations across its three key industries: Food and Beverage (F&B), Real Estate, and Technology. With a strong presence across New Zealand, Australia, and the Philippines, as well as a roadmap for further global expansion, SFIO makes strategic investments in high-growth businesses, building synergies across its diverse portfolio to provide maximum shareholder value. Guided by tradition, driven by innovation, and enabled by collaboration — SFIO is on a hyper-growth path to build a thriving business ecosystem, with plans to uplist onto a major stock exchange in the near future.

About Annapolis Co., Ltd.
Annapolis Company Limited and Food Gravity Company Limited (Annapolis Co., Ltd.) is Thailand’s leading premium ingredients supplier for beverages and bakeries. With two in-house brands, LongBeach Syrup and KAWAMI Premium Tea, their products can be found across major East and Southeast Asian markets.

– Published by The MIL Network

LiveNews: https://livenews.co.nz/2026/03/11/nz-au-sfio-closes-5-m-series-of-global-distribution-partnerships-for-premium-beverages-and-new-zealand-manuka-honey/

Posted on

Nebius expands into Asia-Pacific region to support rapid global growth

Source: Media Outreach

  • Leading AI cloud company to build out presence in Asia-Pacific to tap region’s growth potential
  • Names John Haarer as General Manager for Asia-Pacific and Japan to drive commercial expansion
  • Company is on hypergrowth trajectory following 479% revenue growth in 2025 and contract wins with hundreds of customers, from AI natives to large enterprises

SINGAPORE – EQS Newswire – 10 March 2026 – Nebius (NASDAQ: NBIS), the AI cloud company, today announced the expansion of its operations in the Asia-Pacific region as it seeks to capture surging global demand for purpose-built AI infrastructure. The company has appointed John Haarer as General Manager for Asia-Pacific and Japan to lead its commercial growth across the region.

Reporting to Chief Revenue Officer Marc Boroditsky, Haarer will be based in Singapore and will oversee the company’s commercial expansion across the region through key markets including Singapore, Japan, South Korea and India. Haarer brings over a decade of experience driving go-to-market efforts in the region for global technology leaders including Cloudflare and Twilio.

“Over the past year we have taken our first steps into Asian markets, winning our first customers and building the foundations for rapid expansion in the region,” said Marc Boroditsky, Chief Revenue Officer at Nebius. “The appointment of a leader like John reinforces this commitment. He brings deep regional experience from scaling major tech companies across Asia-Pacific, and he joins at a moment when demand for purpose-built AI infrastructure is accelerating across every major market in the region.”

“Asia is one of the world’s most exciting regions for AI, and Nebius is the cloud that is powering the next wave of AI innovation,” said John Haarer, General Manager for Asia-Pacific and Japan. “I am excited to join a company with some of the world’s most talented engineers at a pivotal moment for the business. As we ramp up in Asia, I look forward to helping our partners, customers and local governments across the region navigate their AI bottlenecks and transform the promise of AI into tangible economic value.”

Nebius is one of the fastest-growing AI cloud companies globally, with 479% year-over-year revenue growth in 2025 and a contract backlog exceeding $20 billion, including multi-year AI infrastructure agreements with Microsoft and Meta. The company has $3.7 billion in cash and is targeting annualized run-rate revenue of $7 billion to $9 billion by end of 2026. Haarer’s appointment marks the company’s shift in Asia-Pacific from initial market entry to full commercial expansion.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which involve risks and uncertainties. All statements contained in this press release other than statements of historical fact, including, without limitation, statements regarding our expansion plans in the Asia-Pacific region, anticipated revenue targets, contract backlog, and expected business growth, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “guide,” “intend,” “likely,” “may,” “will” and similar expressions and their negatives are intended to identify forward-looking statements.

These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. Actual results may differ materially from the results predicted or implied by such statements, and our reported results should not be considered as an indication of future performance. The potential risks and uncertainties that could cause actual results to differ from the results predicted or implied by such statements include, among others: market, macroeconomic and geopolitical conditions; our ability to successfully expand into new geographic markets; competitive pressures; technological developments; and our ability to secure and retain clients; as well as those risks and uncertainties related to our continuing businesses included under the captions “Risk Factors” and “Operating and Financial Review and Prospects” in our Annual Report on Form 20-F for the year ended December 31, 2024, filed with the Securities and Exchange Commission (“SEC”) on April 30, 2025.

All information in this press release is as of the date hereof (unless stated otherwise). Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date hereof and, while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely upon these statements.

Hashtag: #Nebius

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/10/nebius-expands-into-asia-pacific-region-to-support-rapid-global-growth/

Posted on

National Party politicians rule out leadership bid

Source: Radio New Zealand

Education Minister Erica Stanford has often been tipped as a possible leadership contender. RNZ / Marika Khabazi

Education Minister Erica Stanford has been damning in her assessment of last week’s disastrous poll result for National, calling it a “bad week” for the party and for the caucus.

Speculation has been swirling about Prime Minister Christopher Luxon’s leadership after the Taxpayers’ Union Curia Poll result put National on 28.4 per cent – the party’s lowest result since Luxon became leader.

Asked on Tuesday whether she was happy with the result, Stanford – often tipped as a possible leadership contender – said: “No, of course not”.

“We’ve got to do a lot better as a party, all of us pull together, we’ve got to respect what voters are telling us,” she said.

In addition to the horror poll, Luxon also struggled to articulate the government’s position on the Iran conflict and flubbed his answers to questions on the same topic at his post-Cabinet press conference last week.

Asked whether it was a bad week for the prime minister, Stanford said the result reflected poorly on the party.

“I would say it’s a bad week for the National Party and our caucus, and we’ve got to do better all of us together, pull together and remember that our focus is on the New Zealand people, and in my case, raising student achievement,” Stanford said.

Any speculation she was vying for the top job was “reporters interviewing their own typewriters”, Stanford said, adding that she supported the prime minister “100 percent”.

On Tuesday afternoon, Stanford ruled out making any bids for the leadership.

“We have a leader, he’s doing a really good job, and I am part of a high-performing team just doing my job, reforming the education system.”

In a busy day in Parliament – when the Covid-19 inquiry report was released, National MP and Minister Shane Reti announced his retirement, and MP Mariameno Kapa-Kingi was reinstated to Te Pāti Māori by the High Court – National Party ministers and backbenchers were resolute in their support of the prime minister.

Māori Development Minister Tama Potaka said he had “no intentions” to run for the top job. RNZ / Mark Papalii

Māori Development Minister Tama Potaka said he backed Luxon and looked forward to the coming election campaign.

Asked whether he wanted to be the leader, he repeatedly said he had “no intentions” to run for the top job but also refused to rule out a future bid.

“It’s got nothing to do with me… I’m not here to answer questions about me running for the leadership, because, as you know, I support the prime minister.”

Tim Costley, MP for Ōtaki, said that asking Luxon to step down, should his polling worsen, had never crossed his mind.

“We’ve got a strong caucus. We’ve got 49. We’re looking great.”

Banks Peninsula MP Vanessa Weenink said she was not concerned about her seat, which was one of the most marginal at the last election.

“I’m not worried about my job. I’m not worried about my seat. I’m worried about the country if we have an alternative government.”

Takinini MP Rima Nakhle put her level of support for the prime minister at “123 percent”, while Upper Harbour MP Cameron Brewer said the caucus was unified.

“We respect the guy, we’re tight, we’re disciplined, and you can see that with all our answers in the last 72 hours. You know, we actually just want to get on with the job.”

The prime minister himself continued to brush off concerns about the poll, telling reporters on Tuesday that the party’s caucus meeting would feature normal business, adding the team was “really united, really focused, really driven”.

But Labour leader Chris Hipkins blasted National for getting itself into “one heck of a mess”.

“They promised they were going to fix the economy, they’ve shrunk it. They promised they were going to get Kiwis into work, more Kiwis are unemployed now. They promised they were going to fix government debt, government debt’s gone up. They promised they were going to fix the cost of living, the cost of living’s got harder for New Zealand households.

“Whether it’s Christopher Luxon or one of the other ministers who was involved in all of those decisions leading the National Party, the problem is they haven’t done what they said they were going to do.”

Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.

– Published by EveningReport.nz and AsiaPacificReport.nz, see: MIL OSI in partnership with Radio New Zealand

LiveNews: https://livenews.co.nz/2026/03/10/national-party-politicians-rule-out-leadership-bid/

Posted on

China Telecom Concludes MWC 2026 with Outstanding Success

Source: Media Outreach

BARCELONA, SPAIN – Media OutReach Newswire – 9 March 2026 – From March 2 to 5, the 2026 Mobile World Congress (MWC) was grandly held in Barcelona, Spain. China Telecom attended the Congress with two high-profile keynote speeches, an immersive interactive exhibition booth, and a Low-Altitude Economy Launch Event, presenting a panoramic showcase of its strategic vision and innovative achievements in transforming into a key promoter in the AI era. Having also won multiple prestigious international awards in the telecommunications field, China Telecom earned wide attention and high recognition from international operators, ecosystem partners, and global media with its hard-core technological strength and open, collaborative spirit.

China Telecom MWC 2026

Two Keynote Speeches Set the Tone: Charting a New Vision for Transformation in the AI Era

On March 2, China Telecom President Liu Guiqing attended the Congress opening ceremony and delivered a keynote speech entitled “The Transformation of a Large Telco to a Key Promoter in AI Era.” Liu Guiqing stated that China Telecom is fully embracing AI and advancing its corporate strategy toward the “Cloudification, Digital Transformation and AI for Good” upgrade, consistently placing technological innovation at the core of its corporate strategy and driving the company’s transformation from a traditional telecommunications operator into a technology-oriented enterprise.

At the Congress, Liu Guiqing put forward five key judgements on the direction of operator development in the AI era: First, 6G standard innovation and network deployment must fully account for the rapid development of AI. Second, cloud-network integration will play an ever greater role in the AI era. Third, AI security governance will become a mandatory topic for global operators, and is also a watershed defining the strength of operational and service capabilities in the intelligent era. Fourth, computing-power and electricity coordination capability will become the key to the sustainable development of intelligent computing infrastructure. Fifth, the flourishing development of AI applications requires operators to open up and cooperate with greater force.

On March 3, Liu Guiqing attended the World Broadband Association (WBBA) Broadband Development Congress and delivered a keynote speech entitled “From Connectivity to Intelligence: A New Era for Cloud-Network Broadband.” Liu Guiqing noted that AI is fully advancing into the Agentic AI stage — characterized by autonomous execution and intelligent collaboration — heralding the dawn of an Agentic Internet. How to accurately seize the transformational opportunities driven by Agentic AI has become a shared challenge for telecommunications operators worldwide.

Liu Guiqing emphasized that China Telecom is willing to join hands with WBBA and all industry stakeholders, with Agentic AI as the core engine, to drive the iterative upgrade of new digital information infrastructure. Three proposals were put forward: First, to strengthen technological innovation in collaboration with WBBA, leading the transformation of new digital information infrastructure. Second, to deepen industrial cooperation through WBBA, expanding the value of new digital information infrastructure. Third, to leverage WBBA to bridge the global digital and intelligent divide, elevate the standard of global cloud-network services, lower the threshold for applying intelligent technologies, and ensure the dividends of Agentic AI development benefit a broader population.

Multiple Awards, Crowning Honours: International Recognition Sets a New Benchmark

On March 4, at the Global Mobile Awards (GLOMO Awards) — widely regarded as the “Oscars of the mobile communications industry” — China Telecom claimed an impressive haul of four accolades. The EasyOn 5G-A-RobotNet solution, developed jointly with ZTE, won the “Best Private Network Solution Award”; the direct-to-high-orbit satellite connectivity project for mobile phones, co-developed with Huawei, won the “Best Non-Terrestrial Network Solution Award”; the “Green Pepper Programme” in Lancang County, Pu’er, jointly submitted with the YouCheng Foundation and Huawei, won the “Best Mobile Innovation for Enhancing the Lives of Children and Young People Award”; and the “5G-A Empowering a New Model of Wireless Concert Livestreaming” project, developed together with ZTE and other industry partners, won the “Best Event Activation Award.” The multiple awards won underscore China Telecom’s comprehensive strength across technological innovation, social responsibility, and commercial application.

During the Congress, the GSMA Foundry Awards Ceremony was held with great fanfare. Three innovative proposals jointly developed by China Telecom with Huawei and ZTE stood out from the competition, capturing a total of four awards across two categories of the Foundry Excellence Awards 2026 and the GSMA Foundry Innovation GLOMO Award. Specifically, the “Mobile Network for Thriving AI” project, developed jointly with Huawei, received the Intelligent Networks & AI-Driven Infrastructure Award under the GSMA Foundry Excellence Awards; the “5G-Advanced Facilitates Multi-Robot Collaboration” solution, co-developed with ZTE, won the GSMA Foundry “Enterprise Innovation & New Revenue Models” award; and the “Relieving the Pressure on Physicians” solution has claimed both the GSMA Foundry “Cross-Cutting Excellence” Award and the GSMA Foundry Innovation GLOMO Award, demonstrating China Telecom’s globally leading capabilities in the convergence of 5G-A and AI technologies for industry applications.

One Exhibition Booth, One Launch Event: Co-Drawing a New Vision of Intelligence in the AI Era

During this year’s MWC, China Telecom’s exhibition booth was meticulously arranged under the theme “Embracing the Intelligent Era with New AI Infra.” From the stunning debut of the Xirang 2.0 “Triless Three-Independence Architecture,” to the “Xing Xiao Chen Intelligent Agent”‘s multi-task intent understanding and central control capabilities; from the quantum infrastructure covering over 40 major cities across China, to the panoramic vision of a low-altitude intelligent network and satellite communications spanning “air, space, ground, and sea” — China Telecom showcased four major infrastructure pillars, namely “AI + Intelligent Cloud,” “AI + Quantum,” “AI + Low-Altitude,” and “AI + Satellite Communications,” outlining the foundation of the intelligent era with a forward-looking vision and attracting numerous senior executives and professionals from international operators for in-depth exchanges.

On March 2, China Telecom Unmanned Technology held a Low-Altitude Economy Launch Event, unveiling China Telecom’s AI-powered “1+1+4+N” Low-Altitude Economy Capability System to the world. Leveraging key technologies including 5G-Advanced (5G-A), RedCap, millimeter-wave sensing, and Integrated Sensing and Communication (ISAC), China Telecom has built an intelligent connected network with deep integration of “connectivity, sensing, computing, and platform,” forming a full-stack capability system covering low-altitude infrastructure, operational supervision, security protection, and intelligent operations. To date, the Capability System has been deployed in over 60 cities across China, generating more than 1,000 application scenarios, and has achieved application deployment in regions including West Africa, demonstrating mature large-scale rollout capabilities. The event also saw the launch of four digital platforms — Xingyun, Xingdun, Xingxun, and Xinghan — along with the “Tianqing” 5G-A RedCap Low-Altitude Module, delivering integrated and replicable system solutions to help low-altitude flight “fly safely and fly efficiently.”

Throughout the four-day exhibition, technological depth and the warmth of everyday life blended perfectly at the China Telecom booth. This year, the booth featured a dedicated AI Live TechShow, where performers presented China Telecom’s AI technologies and products woven into everyday life scenes in a lighthearted and entertaining way: the eSurf IntelliHub captured real-time footage of mischievous pets at home; the eSurf AI health & wellness companion robot precisely reminded users about their medication; the eSurf AI sports companion robot dog danced in time to the music… Every performance drew crowds of visitors who stopped to watch.

The “AI + Chinese Opera Face-Changing” interactive experience, powered by the Xingchen Large Model and image algorithms, allowed overseas visitors to instantly complete a Chinese opera costume transformation. Exquisite gifts given out on site — including Xing Xiao Chen magnetic snap figurines and panda blind box plushies — proved enormously popular with Congress attendees. This cross-language beauty of AI came with a very real sense of “something to take home,” leaving everyone with wonderful memories.

During the exhibition, mainstream media, industry media, and overseas outlets provided comprehensive coverage of the China Telecom booth through livestreaming, exclusive interviews, articles, and other formats, sparking extensive attention and discussion, with related topics trending continuously. On March 3, well-known media hosts took up position at the China Telecom booth and launched a global “Exhibition Exploration” livestream, offering tens of millions of online viewers an immersive, first-person experience of the cutting-edge technologies, igniting wave after wave of online buzz. China Telecom’s AI products and technological capabilities successfully achieved breakthrough viral reach well beyond the industry.

This MWC 2026 journey was not only a vivid demonstration of China Telecom’s transformation into a key promoter in the AI era, but also a profound dialogue with global partners on technology and development. Standing at the forefront of the intelligent era, China Telecom will continue to deepen its “Cloudification, Digital Transformation and AI for Good” strategy, responding to the questions of the times with forward-looking technological innovation, and moving forward hand in hand with partners in an open and mutually beneficial spirit, jointly ushering in a brighter new era of AI.

https://www.chinatelecomglobal.com/
https://www.linkedin.com/company/3679513
https://x.com/chinateleglobal
https://www.facebook.com/chinatelecomglobal
Wechat: 中国电信国际

Hashtag: #ChinaTelecom #MWC2026 #AI #DigitalTransformation

The issuer is solely responsible for the content of this announcement.

– Published and distributed with permission of Media-Outreach.com.

LiveNews: https://livenews.co.nz/2026/03/09/china-telecom-concludes-mwc-2026-with-outstanding-success/

Posted on

Politics live: Christopher Luxon responds to poll result

Source: Radio New Zealand

Finance minster Nicola Willis is joining Christopher Luxon at the weekly post-Cabinet media conference, with an update on the economy. But attention is likely to fall on the Prime Minister with questions about his leadership, the polls and Iran.

Follow all the latest news with RNZ’s live blog.

The prime minister is facing disastrous poll numbers, while also dealing with global issues, as missiles continue to tear through Middle Eastern skies.

Pressure is mounting on the Christopher Luxon with a poll result last week putting National in the 20s.

Listen to the PM’s appearance on Morning Report here:

Luxon batted away questions last week about stepping down as party leader following the latest Taxpayers’ Union Curia poll that had National on 28.4 – down nearly 3 points from its poll last month.

Luxon said on Friday evening none of his Cabinet colleagues had told him to reconsider his future, saying “all of them” back him.

He said he was “absolutely not” considering standing down and said he had the skills to lead the National Party and the country.

Luxon also made a personal explanation in the House on Tuesday night, after he stated incorrectly the government was automatically extending visas for people in New Zealand affected by the war in Iran.

RNZ / Angus Dreaver

Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.

– Published by EveningReport.nz and AsiaPacificReport.nz, see: MIL OSI in partnership with Radio New Zealand

LiveNews: https://livenews.co.nz/2026/03/09/politics-live-christopher-luxon-responds-to-poll-result/